UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
x | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the quarterly period ended September 30, 2004
or
¨ | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the transition period from to
Commission File Number 0-25996
TRANSWITCH CORPORATION
(Exact name of Registrant as Specified in its Charter)
Delaware | 06-1236189 | |
(State of Incorporation) | (I.R.S. Employer Identification Number) |
3 Enterprise Drive
Shelton, Connecticut 06484
(Address of Principal Executive Offices)
Telephone (203) 929-8810
(Registrants telephone number, including area code)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Act). Yes x No ¨
At October 25, 2004, there were 94,528,578 shares of Common Stock, par value $.001 per share, of the Registrant outstanding.
TRANSWITCH CORPORATION AND SUBSIDIARIES
FORM 10-Q
For the Quarterly Period Ended September 30, 2004
Table of Contents
Page | ||||
PART I. FINANCIAL INFORMATION | ||||
Item 1. |
Financial Statements (unaudited) | |||
Consolidated Balance Sheets as of September 30, 2004 and December 31, 2003 | 3 | |||
Consolidated Statements of Operations for the three and nine months ended September 30, 2004 and 2003 | 4 | |||
Consolidated Statements of Cash Flows for the nine months ended September 30, 2004 and 2003 | 5 | |||
Notes to Unaudited Consolidated Financial Statements | 6 | |||
Item 2. |
Managements Discussion and Analysis of Financial Condition and Results of Operations | 15 | ||
Item 3. |
Quantitative and Qualitative Disclosures about Market Risk | 41 | ||
Item 4. |
Controls and Procedures | 42 | ||
Item 1. |
Legal Proceedings | 43 | ||
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds | 43 | ||
Item 6. |
Exhibits | 44 | ||
Signatures | 45 |
2
TRANSWITCH CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
September 30, 2004 |
December 31, 2003 |
|||||||
(unaudited) | ||||||||
ASSETS | ||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 83,254 | $ | 142,950 | ||||
Short-term investments |
26,261 | 9,101 | ||||||
Accounts receivable, net |
3,856 | 3,684 | ||||||
Inventories |
2,817 | 2,838 | ||||||
Prepaid expenses and other current assets |
2,833 | 2,912 | ||||||
Total current assets |
119,021 | 161,485 | ||||||
Long-term marketable securities |
33,421 | 27,300 | ||||||
Property and equipment, net |
6,357 | 10,262 | ||||||
Patents, net of accumulated amortization |
1,120 | 1,240 | ||||||
Investments in non-publicly traded companies |
1,889 | 627 | ||||||
Deferred financing costs, net |
3,313 | 4,462 | ||||||
Other assets |
759 | 930 | ||||||
Total assets |
$ | 165,880 | $ | 206,306 | ||||
LIABILITIES AND STOCKHOLDERS EQUITY | ||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 2,335 | $ | 664 | ||||
Accrued expenses and other current liabilities |
5,558 | 6,728 | ||||||
Accrued compensation and benefits |
2,217 | 1,458 | ||||||
Accrued sales returns, allowances and stock rotation |
923 | 1,671 | ||||||
Accrued interest |
58 | 1,665 | ||||||
Restructuring liabilities |
1,199 | 1,454 | ||||||
4.50% Convertible Notes due 2005 |
24,442 | | ||||||
Total current liabilities |
36,732 | 13,640 | ||||||
Restructuring liabilities long-term |
21,818 | 22,689 | ||||||
5.45% Convertible Plus Cash NotesSM due 2007, net of debt discount of $16,393 and $21,742, respectively |
75,626 | 75,866 | ||||||
4.50% Convertible Notes due 2005 |
| 24,442 | ||||||
Derivative liability |
7,807 | 20,659 | ||||||
Total liabilities |
141,983 | 157,296 | ||||||
Commitments and contingencies |
||||||||
Stockholders equity: |
||||||||
Common stock, $.001 par value; 300,000,000 shares authorized; 94,521,077 and 90,953,205 shares issued and outstanding at September 30, 2004 and December 31, 2003, respectively |
94 | 91 | ||||||
Additional paid-in capital |
296,959 | 291,115 | ||||||
Accumulated other comprehensive income |
725 | 994 | ||||||
Accumulated deficit |
(273,881 | ) | (243,190 | ) | ||||
Total stockholders equity |
23,897 | 49,010 | ||||||
Total liabilities and stockholders equity |
$ | 165,880 | $ | 206,306 | ||||
See accompanying notes to unaudited consolidated financial statements.
3
TRANSWITCH CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
2004 |
2003 |
2004 |
2003 |
|||||||||||||
Net revenues: |
||||||||||||||||
Product revenues |
$ | 8,336 | $ | 5,264 | $ | 25,040 | $ | 15,711 | ||||||||
Service revenues |
12 | 421 | 200 | 679 | ||||||||||||
Total net revenues |
8,348 | 5,685 | 25,240 | 16,390 | ||||||||||||
Cost of revenues: |
||||||||||||||||
Cost of product revenues |
2,498 | 1,502 | 6,890 | 4,499 | ||||||||||||
Provision for excess and obsolete inventories |
571 | | 571 | 1,498 | ||||||||||||
Cost of service revenues |
2 | 110 | 160 | 226 | ||||||||||||
Total cost of revenues |
3,071 | 1,612 | 7,621 | 6,223 | ||||||||||||
Gross profit |
5,277 | 4,073 | 17,619 | 10,167 | ||||||||||||
Operating expenses: |
||||||||||||||||
Research and development |
11,230 | 10,656 | 36,871 | 31,354 | ||||||||||||
Marketing and sales |
2,789 | 2,784 | 9,332 | 8,176 | ||||||||||||
General and administrative |
1,506 | 1,374 | 5,169 | 4,094 | ||||||||||||
Restructuring charge (benefit) and asset impairments, net |
492 | (860 | ) | 280 | 3,064 | |||||||||||
Purchased in-process research and development |
| 476 | | 476 | ||||||||||||
Total operating expenses |
16,017 | 14,430 | 51,652 | 47,164 | ||||||||||||
Operating loss |
(10,740 | ) | (10,357 | ) | (34,033 | ) | (36,997 | ) | ||||||||
Other income (expense): |
||||||||||||||||
Impairment of investments in non-publicly traded companies |
| | (123 | ) | (50 | ) | ||||||||||
Equity in net losses of affiliates |
| (582 | ) | (1,368 | ) | |||||||||||
Gain from exchange and repurchase of 4.50% Convertible Notes due 2005 |
| 14,463 | 14,463 | |||||||||||||
Change in fair value of derivative liability |
5,126 | | 12,852 | | ||||||||||||
Loss on extinguishment of debt |
| | (1,241 | ) | | |||||||||||
Other income |
| | 378 | | ||||||||||||
Interest income (expense): |
||||||||||||||||
Interest income |
577 | 727 | 1,708 | 2,312 | ||||||||||||
Interest expense |
(3,227 | ) | (1,558 | ) | (9,792 | ) | (4,596 | ) | ||||||||
Interest expense, net |
(2,650 | ) | (831 | ) | (8,084 | ) | (2,284 | ) | ||||||||
Total other income, net |
2,476 | 13,050 | 3,782 | 10,761 | ||||||||||||
(Loss) income before income taxes, extraordinary loss and cumulative effect of adoption of and changes in accounting principles |
(8,264 | ) | 2,693 | (30,251 | ) | (26,236 | ) | |||||||||
Income tax (benefit) expense |
(10 | ) | 73 | 163 | 257 | |||||||||||
(Loss) income before extraordinary loss and cumulative effect of adoption of and changes in accounting principles |
(8,254 | ) | 2,620 | (30,414 | ) | (26,493 | ) | |||||||||
Extraordinary loss upon consolidation of TeraOp (USA), Inc. |
| | (83 | ) | ||||||||||||
Cumulative effect on prior years of adoption of and retroactive application of FIN 46R and new depreciation method |
| | (277 | ) | (805 | ) | ||||||||||
Net (loss) income |
$ | (8,254 | ) | $ | 2,620 | $ | (30,691 | ) | $ | (27,381 | ) | |||||
Basic and diluted (loss) income per common share: |
||||||||||||||||
(Loss) income before extraordinary loss and cumulative effect of adoption of and changes in accounting principles |
$ | (0.09 | ) | $ | 0.03 | $ | (0.33 | ) | $ | (0.29 | ) | |||||
Extraordinary loss upon consolidation of TeraOp (USA), Inc. |
| | | |||||||||||||
Cumulative effect on prior years of adoption of and retroactive application of FIN 46R and new depreciation method |
| | | (0.01 | ) | |||||||||||
Net (loss) income |
$ | (0.09 | ) | $ | 0.03 | $ | (0.33 | ) | $ | (0.30 | ) | |||||
Basic average common shares outstanding |
94,497 | 90,451 | 92,705 | 90,261 | ||||||||||||
Diluted average common shares outstanding |
94,497 | 92,698 | 92,705 | 90,261 |
See accompanying notes to unaudited consolidated financial statements.
4
TRANSWITCH CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
Nine Months Ended September 30, |
||||||||
2004 |
2003 |
|||||||
Cash flows from operating activities: |
||||||||
Net loss |
$ | (30,691 | ) | $ | (27,381 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
Depreciation and amortization |
12,839 | 9,029 | ||||||
Provision for excess and obsolete inventories |
571 | 1,498 | ||||||
Provision for doubtful accounts |
16 | 7 | ||||||
Cumulative effect on prior years of adoption of and retroactive application of FIN 46R and new depreciation method |
277 | 805 | ||||||
Loss on extinguishment of debt |
1,241 | | ||||||
Extraordinary loss upon consolidation of TeraOp (USA), Inc. |
| 83 | ||||||
Non-cash restructuring benefit and asset impairments, net |
(173 | ) | (474 | ) | ||||
Equity in net losses of affiliates |
| 1,368 | ||||||
Impairment of investments in non-publicly traded companies |
123 | 50 | ||||||
Purchased in-process research and development |
| 476 | ||||||
Gain from exchange and repurchase of 4.50% Convertible Notes due 2005 |
| (14,463 | ) | |||||
Change in fair value of derivative liability |
(12,852 | ) | | |||||
Other non-cash items |
59 | | ||||||
Changes in assets and liabilities, net of effects of acquisitions: |
||||||||
Accounts receivable |
(188 | ) | (260 | ) | ||||
Inventories |
(550 | ) | 352 | |||||
Prepaid expenses and other assets |
162 | 1,109 | ||||||
Accounts payable |
1,152 | (965 | ) | |||||
Accrued expenses and other current liabilities |
(2,755 | ) | (4,260 | ) | ||||
Restructuring liabilities |
(996 | ) | (1,458 | ) | ||||
Net cash used in operating activities |
(31,765 | ) | (34,484 | ) | ||||
Cash flows from investing activities: | ||||||||
Capital expenditures |
(3,369 | ) | (1,329 | ) | ||||
Investments in non-publicly traded companies |
(1,385 | ) | (1,374 | ) | ||||
Cash received from dissolution of investment |
| 886 | ||||||
Acquisition of businesses, net of cash acquired |
| (354 | ) | |||||
Cash acquired upon consolidation of variable interest entities |
124 | 17 | ||||||
Purchases of short and long-term held-to-maturity investments |
(91,776 | ) | (49,017 | ) | ||||
Proceeds from maturities of short and long-term held-to-maturity investments |
68,494 | 58,120 | ||||||
Net cash (used in) provided by investing activities |
(27,912 | ) | 6,949 | |||||
Cash flows from financing activities: | ||||||||
Issuance of common stock under employee stock plans |
309 | 319 | ||||||
Payment in lieu of interest on extinguishment of debt |
(59 | ) | | |||||
Proceeds from the issuance of 5.45% Convertible Plus Cash NotesSM due 2007, net of deferred financing fees |
| 19,573 | ||||||
Net cash provided by financing activities |
250 | 19,892 | ||||||
Effect of exchange rate changes on cash and cash equivalents |
(269 | ) | 310 | |||||
Decrease in cash and cash equivalents |
(59,696 | ) | (7,333 | ) | ||||
Cash and cash equivalents at beginning of period |
142,950 | 150,548 | ||||||
Cash and cash equivalents at end of period |
$ | 83,254 | $ | 143,215 | ||||
See accompanying notes to unaudited consolidated financial statements.
5
TRANSWITCH CORPORATION AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements
(Tabular dollars in thousands, except share and per share amounts)
Note 1. Summary of Significant Accounting Policies
Description of Business
TranSwitch Corporation was incorporated in Delaware on April 26, 1988, and is headquartered in Shelton, Connecticut. The Company and its subsidiaries (collectively, TranSwitch or the Company) design, develop, market and support highly integrated digital and mixed-signal semiconductor devices for the telecommunications and data communications industries.
Basis of Presentation Interim Financial Statements
The unaudited interim consolidated financial statements include the accounts of TranSwitch Corporation and its wholly-owned subsidiaries and its variable interest entities for which the Company is the primary beneficiary. All significant intercompany accounts and transactions have been eliminated. The accompanying unaudited interim consolidated financial statements of TranSwitch have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission for reporting on Form 10-Q. Accordingly, certain information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements are not included herein. The unaudited interim consolidated financial statements are prepared on a consistent basis with, and should be read in conjunction with, the audited consolidated financial statements and the related notes thereto as of and for the year ended December 31, 2003, contained in the Companys Annual Report on Form 10-K for the year ended December 31, 2003, filed with the Securities and Exchange Commission on March 3, 2004.
In the opinion of management, the accompanying unaudited interim consolidated financial statements include all adjustments, consisting of normal recurring adjustments, which are necessary for a fair presentation for such periods. The results of operations for any interim period are not necessarily indicative of the results that may be achieved for the full year.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions. Estimates are used in accounting for, among other things, allowances for uncollectible receivables, excess or slow-moving inventories, obsolete inventories, impairment of assets, product warranty reserves, depreciation and amortization, income taxes, sales returns, stock rotation and contingencies. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the financial statements in the period they are determined to be necessary.
Stock-Based Compensation
As permitted by Statement of Financial Accounting Standard (SFAS), No. 123, Accounting for Stock-Based Compensation, (SFAS 123), the Company accounts for employee stock-based compensation in accordance with Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to Employees (APB 25), and the Financial Accounting Standards Board (FASB) Interpretation (FIN) No. 44, Accounting for Certain Transactions Involving Stock-Based Compensation, an interpretation of APB Opinion No. 25 (FIN 44) and related interpretations. In addition, the Company provides pro forma disclosure of stock-based compensation, as measured under the fair value requirements of SFAS 123. These pro forma disclosures are provided as required under SFAS No. 148, Accounting for Stock-Based Compensation-Transition and Disclosure (SFAS 148), which amends the disclosure requirements of SFAS 123 to require more prominent disclosures in both annual and interim financial statements about the method of accounting for stock-based employee compensation and the effect of the method used on reported results.
6
TRANSWITCH CORPORATION AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements
(Tabular dollars in thousands, except share and per share amounts)
In accordance with SFAS 123, the fair value of options granted to employees, which is amortized to expense over the option vesting period in determining the pro forma impact, is estimated on the date of the grant using the Black-Scholes option-pricing model. The following table illustrates the effect on net loss and loss per common share as if the Black-Scholes fair value method prescribed by SFAS 123 had been applied to the Companys long-term compensation equity plans:
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
2004 |
2003 |
2004 |
2003 |
|||||||||||||
Net (loss) income: |
||||||||||||||||
Reported net (loss) income: |
$ | (8,254 | ) | $ | 2,620 | $ | (30,691 | ) | $ | (27,381 | ) | |||||
Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards |
(3,687 | ) | (9,454 | ) | (12,129 | ) | (29,217 | ) | ||||||||
Pro forma loss |
$ | (11,941 | ) | $ | (6,834 | ) | $ | (42,820 | ) | $ | (56,598 | ) | ||||
Basic (loss) income per common share: |
||||||||||||||||
As reported |
$ | (0.09 | ) | $ | 0.03 | $ | (0.33 | ) | $ | (0.30 | ) | |||||
Pro forma |
$ | (0.13 | ) | $ | (0.08 | ) | $ | (0.46 | ) | $ | (0.63 | ) | ||||
Diluted (loss) income per common share: |
||||||||||||||||
As reported |
$ | (0.09 | ) | $ | 0.03 | $ | (0.33 | ) | $ | (0.30 | ) | |||||
Pro forma |
$ | (0.13 | ) | $ | (0.07 | ) | $ | (0.46 | ) | $ | (0.63 | ) |
The fair value of each option grant is estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions:
September 30, |
||||||
2004 |
2003 |
|||||
Risk-free interest rate |
3.40 | % | 2.85 | % | ||
Expected life in years |
2.38 | 1.99 | ||||
Expected volatility |
100.00 | % | 100.03 | % | ||
Expected dividend yield |
| |
In accordance with SFAS 123, the weighted average fair value of stock options granted to employees was based on a theoretical statistical model using assumptions. However, because our stock options are not traded on any exchange, employees can receive no value or derive any benefit from holding stock options under these plans without an increase in the market price of our common stock relative to the respective dates of the option grants.
(Loss) income Per Common Share
Basic (loss) income per common share is based upon the weighted average common shares outstanding during the period. Diluted (loss) income per common share assumes exercise of all outstanding in-the-money stock options for the three and nine months ended September 30, 2004 and 2003, respectively, and the conversion of the 4.50% Convertible Notes due 2005 and 5.45% Convertible Plus Cash NotesSM due 2007 into common stock at the beginning of the period or the date of issuance, if later, unless they are anti-dilutive.
Recent Accounting Pronouncement
In January 2003, the FASB issued Interpretation No. 46, Consolidation of Variable Interest Entities, an interpretation of ARB 51 (FIN 46). The interpretation provided guidance on consolidating variable interest entities and applied immediately to variable interests created after January 31, 2003. The guidelines of the interpretation as revised by FIN 46 (revised December 2003), Consolidation of Variable Interest Entities (FIN 46R) became applicable to the Company in the first quarter of 2004 for variable interest entities created before February 1, 2003. The interpretation requires variable interest entities to be consolidated if the equity investment at risk is not sufficient to permit an entity to finance its activities without support from other parties, or the equity investors lack certain specified characteristics.
Changes in Accounting Principles
The Company adopted the provisions of FIN 46R and changed its accounting accordingly in the first quarter of 2004. As a result of the adoption of FIN 46R, the Company consolidated the results of its investment in OptiX Networks, Inc. (OptiX) and recorded a charge of $0.3 million for the nine months ended September 30, 2004, as a cumulative effect of an accounting change. This charge has not been presented net of income taxes since the Company continues to maintain a full valuation allowance against net deferred income tax assets. Refer also to Note 5 - Investments in Non-Publicly Traded Companies.
7
TRANSWITCH CORPORATION AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements
(Tabular dollars in thousands, except share and per share amounts)
As disclosed in the Companys Annual Report on Form 10-K for the year ended December 31, 2003, as filed with the Securities and Exchange Commission on March 3, 2004, the Company changed the method of depreciating property and equipment to the straight-line method effective January 1, 2003. Depreciation of property and equipment in prior years was computed using the half-year convention method. The effect of the change in depreciation method as of January 1, 2003 was applied retroactively to property and equipment acquisitions of prior years. The cumulative effect of the change with respect to the retroactive application of the straight-line method was approximately a $0.8 million charge and has been recorded as such on the consolidated statements of operations for the nine months ended September 30, 2003. This charge has not been presented net of income taxes since the Company continues to maintain a full valuation allowance against net deferred income tax assets.
Note 2. Inventories
The components of inventories at September 30, 2004 and December 31, 2003 are as follows:
September 30, 2004 |
December 31, 2003 | |||||
Raw materials |
$ | 446 | $ | 643 | ||
Work-in-process |
789 | 488 | ||||
Finished goods |
1,582 | 1,707 | ||||
Total inventories |
$ | 2,817 | $ | 2,838 | ||
During the three months ended September 30, 2004 and 2003, the Company recorded provisions for excess and obsolete inventories of approximately $0.6 million and zero, respectively. The Company recorded provisions for excess and obsolete inventories totaling approximately $0.6 million and $1.5 million for the nine months ended September 30, 2004 and 2003 respectively, and $1.5 million, $4.8 million and $39.2 million during the years ended December 31, 2003, 2002 and 2001, respectively. The effect of these inventory provisions was to write this excess inventory down to a new cost basis of zero. During the three and nine months ended September 30, 2004 and 2003, the Company sold certain products that had previously been written down to a cost basis of zero. The following tables present the beneficial impact to gross profit from the sale of this previously written down inventory for the three and nine months ended September 30, 2004 and 2003:
Three Months Ended September 30, 2004 |
Three Months Ended September 30, 2003 |
|||||||||||||
Gross Profit $ |
Gross Profit % |
Gross Profit $ |
Gross Profit % |
|||||||||||
Gross profit as reported |
$ | 5,277 | 63 | % | $ | 4,073 | 72 | % | ||||||
Excess inventory benefit(1) |
(1,025 | ) | (12 | )% | (602 | ) | (11 | )% | ||||||
Excess inventory charge(2) |
571 | 7 | % | | | % | ||||||||
Gross profit as adjusted |
$ | 4,823 | 58 | % | $ | 3,471 | 61 | % | ||||||
Nine Months Ended September 30, 2004 |
Nine Months Ended September 30, 2003 |
|||||||||||||
Gross Profit $ |
Gross Profit % |
Gross Profit $ |
Gross Profit % |
|||||||||||
Gross profit as reported |
$ | 17,619 | 70 | % | $ | 10,167 | 62 | % | ||||||
Excess inventory benefit(1) |
(3,178 | ) | (13 | )% | (2,948 | ) | (18 | )% | ||||||
Excess inventory charge(2) |
571 | 2 | % | 1,498 | 9 | % | ||||||||
Gross profit as adjusted |
$ | 15,012 | 59 | % | $ | 8,717 | 53 | % | ||||||
(1) | The Company realized an excess inventory benefit from the sale of products that had previously been written down to a cost basis of zero. For the purposes of comparing the change in gross profit on net revenues, the Company is excluding this benefit and calculating gross profit on these product revenues as if they had been sold at their approximate historical average costs. |
(2) | The Company recorded excess and obsolete inventory charges totaling $0.6 million and zero during the three months ended September 30, 2004 and 2003, respectively. The Company recorded excess and obsolete inventory charges totaling $0.6 million and $1.5 million during the nine months ended September 30, 2004 and 2003, respectively. |
8
TRANSWITCH CORPORATION AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements
(Tabular dollars in thousands, except share and per share amounts)
Note 3. Comprehensive (Loss) Income
The components of comprehensive (loss) income for the three and nine months ended September 30, 2004 and 2003 are as follows:
Three Months Ended September 30, |
Nine Months Ended September 30, |
||||||||||||||
2004 |
2003 |
2004 |
2003 |
||||||||||||
Net (loss) income |
$ | (8,254 | ) | $ | 2,620 | $ | (30,691 | ) | $ | (27,381 | ) | ||||
Foreign currency translation adjustment |
30 | 54 | (269 | ) | 310 | ||||||||||
Total comprehensive (loss) income |
$ | (8,224 | ) | $ | 2,674 | $ | (30,960 | ) | $ | (27,071 | ) | ||||
Note 4. Restructuring Liabilities
During the three months ended September 30, 2004, the Company recorded restructuring charges totaling $0.5 million resulting from the Companys liquidation of its investment in TeraOp (USA), Inc. (TeraOp) and the wind-down of the business and operations of OptiX, two Israeli development stage companies consolidated in the Companys financial statements under FIN 46R.
In July 2004, The Company informed OptiX that it planned to discontinue its ongoing funding of OptiXs operations. Consequently, the OptiX Board of Directors voted to wind-down its business and operations. OptiX expects to have the wind-down completed and to permanently close its operations by December 31, 2004. In the three months ended September 30, 2004, the Company recorded a provision of $0.2 million related to the wind-down of OptiX, of which $0.1 million was to reserve for severance costs and $0.1 million was to record the impairment of certain OptiX assets. The Company expects to record additional charges in the fourth quarter of 2004 for severance and lease buy-out costs. Upon the completion of the wind-down, OptiX will be deconsolidated from the Companys financial statements.
In September 2004, the Company entered an agreement with TeraOp under which the Company converted its promissory notes issued and payable by TeraOp into shares of TeraOp common stock. The Company then sold all of its common share holdings in TeraOp to an independent third party for a nominal amount. In addition, the Company paid TeraOp $0.3 million for a royalty on future revenues of TeraOp. Currently TeraOp has no revenue and may never have revenue in the future. As a result of these transactions, the Company no longer holds any equity or debt interest in TeraOp and has no influence over the operations of TeraOp. Accordingly, TeraOp was deconsolidated from the Companys financial statements upon the completion of these transactions, resulting in a net restructuring charge of $0.2 million.
In the nine months ended September 30, 2004, restructuring charges totaled $0.3 million, reflecting the charges totaling $0.5 million resulting from the Companys liquidation of its investment in TeraOp and the wind-down of the business and operations of OptiX, partially offset by changes in the estimated fair value of the liability for future excess facility costs recorded in 2003.
In January 2003, the Company announced a restructuring plan in order to lower its operating expense run-rate due to then current and anticipated business conditions. This plan resulted in a workforce reduction of approximately 24% of existing personnel. Also, the Company announced the closing of its South Brunswick, New Jersey (formerly known as Systems On Silicon, Inc. and referred to as SOSi) design center and the reduction of staff in its Boston, Massachusetts and Shelton, Connecticut offices. This workforce reduction also impacted the Companys Switzerland and Belgium locations. In addition, the Company has postponed the completion of the Integrated Access Device (IAD) product line and archived the related intellectual property until that market returns, if ever. During the nine months ended September 30, 2003, the Company incurred approximately $3.4 million in restructuring expenses related to employee termination benefits and $0.5 million related to excess facility costs. In addition, the Company determined that fixed assets with a net book value totaling $0.3 million and a patent on its IAD product line with a net book value of $0.2 million were impaired for the nine months ended September 30, 2003. This resulted in a total restructuring charge and asset impairment for the nine months ended September 30, 2003 totaling $4.4 million. This restructuring charge was reduced by $1.3 million as the Company was able to sub-lease portions of its excess facilities and by adjustments to original estimates of severance costs related to previously announced restructuring programs.
9
TRANSWITCH CORPORATION AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements
(Tabular dollars in thousands, except share and per share amounts)
The Company adopted SFAS No. 146, Accounting for Costs Associated with Exit or Disposal Activities (SFAS 146) as of January 1, 2003. SFAS 146 requires that a liability for a cost associated with an exit or disposal activity be recognized when the liability is incurred rather than being recognized at the date of the Companys commitment to an exit plan. SFAS 146 also requires that the liability be established at estimated fair value and adjusted in future periods for changes in estimated cash flows. Accordingly, the liability for future excess facility costs recorded in 2003 was recorded net of estimated future sub-lease income (although there were no firm sub-lease commitments) and discounted to current net present value resulting in a net liability of $0.1 million. This liability is adjusted quarterly based upon actual cash flows and changes to estimates. Quarterly adjustments to this liability are recorded as restructuring expenses on the consolidated statements of operations.
A summary of the restructuring liabilities and the activity from December 31, 2003 through September 30, 2004 is as follows:
Restructuring Liabilities December 31, 2003 |
Cash Payments January 1, 2004 September 30, 2004 |
Adjustments and Changes to Estimates |
Restructuring Liabilities September 30, 2004 | |||||||||||
Facility lease costs |
$ | 24,143 | $ | (1,097 | ) | $ | (164 | ) | $ | 22,882 | ||||
Severance costs |
| | 135 | 135 | ||||||||||
Totals |
$ | 24,143 | $ | (1,097 | ) | $ | (29 | ) | $ | 23,017 | ||||
At September 30, 2004 and December 31, 2003, the Company has classified approximately $21.8 million and $22.7 million, respectively of this restructuring liability as long-term, representing net lease commitments that are not due in the succeeding twelve-month period.
During the three months ended September 30, 2004, the Company began the process of exploring alternatives to disengage from its research and development subsidiary in Belgium. Alternatives under consideration include permanent closure of the unit as well as the sale of all or part of the unit. At this time, the Company is in the early stages of this evaluation process and has not committed to any plan.
Note 5. Investments in Non-Publicly Traded Companies
Variable Interest Entities
In January 2003, FIN 46, Consolidation of Variable Interest Entities (FIN 46) was issued. The interpretation provided guidance on consolidating variable interest entities and applied to all variable interests created after January 31, 2003. The interpretation required variable interest entities to be consolidated if the equity investment at risk was not sufficient to permit an entity to finance its activities without support from other parties or the equity investors lack certain specified characteristics. The Company adopted FIN 46 as of February 1, 2003, which resulted in the Company consolidating the results of TeraOp.
During the first quarter of 2003, the Company loaned TeraOp $0.5 million under a new convertible loan agreement, which provided the Company with additional contractual rights over existing debt or equity investors. In addition, the Company also was in a position, as a result of the loan, to negotiate a more favorable conversion price of the equity securities of TeraOp and acquired the ability to control the operations of TeraOp. None of the existing debt or equity investors, other than the Company, was expected to absorb any additional losses from their investment given that the value of the equity in TeraOp was negative as of January 31, 2003. As a result, the convertible loan was determined to be a variable interest and TeraOp was considered a variable interest entity, as defined by FIN 46. The Company calculated the effect of the initial measurement as of January 31, 2003. As a result of this measurement and consolidation of TeraOp, the Company recognized an extraordinary loss of approximately $0.1 million for the nine months ended September 30, 2003, as the fair value of TeraOps liabilities exceeded its assets by this amount. All significant intercompany balances, including the Companys investments in TeraOp, have been eliminated in consolidation. In September 2004, the Company liquidated its investment in TeraOp and deconsolidated TeraOp from the Companys financial statements. For further discussion, please refer to Note 4 Restructuring Liabilities.
The Company adopted the provisions of FIN 46R and changed its accounting accordingly in the first quarter of 2004. As a result of the adoption of FIN 46R, the Company consolidated the results of its investment in OptiX and recorded a charge of
10
TRANSWITCH CORPORATION AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements
(Tabular dollars in thousands, except share and per share amounts)
approximately $0.3 million for the nine months ended September 30, 2004 as a cumulative effect of this accounting change. As disclosed in the Companys Annual Report on Form 10-K for the year ended December 31, 2003, the Company restated prior period results to reflect the change from the cost to the equity method of accounting for its investment in OptiX as the Company, during fiscal 2002, obtained the ability to significantly influence the operating and financial policies of OptiX through its investments in convertible preferred stock and a bridge loan. This investment restatement reduced the investment balance in OptiX (included in investments in non-publicly traded companies on the consolidated balance sheets), as if accounted for on the equity method, since inception. The Board of Directors of OptiX has voted to wind-down its business and operations and upon the completion of the wind-down, OptiX will be deconsolidated from the Companys financial statements. For further discussion, please refer to Note 4 Restructuring Liabilities.
Cost Method Investments
The Company owns shares of convertible preferred stock in Accordion Networks, Inc. (Accordion) and Opulan Networks, Inc. (Opulan). In addition, the Company has a 3% limited partnership interest in Neurone Ventures II, L.P., a venture capital fund organized as a limited partnership. The Companys direct and indirect voting interest (which include certain board members and employees) is less than 20% of the total ownership of each of these companies as of September 30, 2004 and December 31, 2003, and the Company does not exercise significant influence over the management of these companies as defined by APB Opinion No. 18, The Equity Method of Accounting for Investments in Common Stock, and other relevant literature. The Company accounts for these investments at cost and monitors the carrying value of these investments for impairment.
During the first quarter of 2004, the Company advanced $0.1 million to Metanoia Technologies, Inc (Metanoia) under a bridge loan agreement. During the second quarter ended June 30, 2004, the Company purchased shares of Metanoias Series A Preferred Stock through the conversion of the $0.1 million bridge loan and the payment of an additional $0.5 million to Metanoia. During the three months ended September 30, 2004, the Company made an additional $0.4 million investment in Metanoia by purchasing additional shares of Metanoias Series A Preferred Stock for a total investment of $1.0 million. The Companys holdings represent less than 10% of Metanoias outstanding voting stock. Accordingly, the Company is accounting for this investment under the cost method.
Impairment of Investments in Non-Publicly Traded Companies
For the three and nine months ended September 30, 2004 and 2003, as a result of Company-specific and industry conditions, the Company determined that there were indicators of impairment to the carrying value of its investments in non-publicly traded companies. The process of assessing whether a particular investments net realizable value is less than its carrying cost requires a significant amount of judgment. In making this judgment, the Company carefully considers the investees cash position, projected cash flows (both short- and long-term), financing needs, most recent valuation data, the current investing environment, management / ownership changes, and competition. This evaluation process is based on information that the Company requests from these privately-held companies. This information is not subject to the same disclosure and audit requirements as the reports required of U.S. public companies, and as such, the reliability and accuracy of the data may vary. During the nine months ended September 30, 2004 and 2003, the Company used the modified equity method of accounting to measure the impairment loss for its investments in Accordion and Intellectual Capital for Integrated Circuits, Inc. (IC4IC), as the Company determined that no better current evidence of the value of its cost method investments existed and it believes that this measurement process gives the Company the best basis for an estimate given the negative cash flows of these companies. The modified equity method of accounting results in recording an impairment loss on a cost method investment equal to the investors proportionate share of the investees losses as its contributed capital is consumed to fund operating losses of the investee from the inception of the investors investment.
In addition, the Company also evaluated all outstanding bridge loans under SFAS No. 114, Accounting by Creditors for Impairment of a Loan (SFAS 114) which it had not already impaired under the modified equity method of accounting. Under SFAS 114, a loan is considered impaired, based on current information and events, if it is probable that the Company will be unable to collect the scheduled payments of principal or interest when due according to the contractual terms of the loan agreement. The measurement of impaired loans is generally based on the present value of expected future cash flows discounted at the historical effective interest rate, except that all collateral-dependent loans are measured for impairment based on the fair value of the collateral.
Based on our evaluations, we recorded impairment charges related to our remaining investments in convertible debt in Accordion of $0.1 million during the nine months ended September 30, 2004. During the first quarter of 2004, the Company decided to stop funding the operations of Accordion. The Board of Directors of Accordion voted to discontinue the operations of Accordion in March 2004.
11
TRANSWITCH CORPORATION AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements
(Tabular dollars in thousands, except share and per share amounts)
In February 2003, the Company made a convertible bridge loan investment in IC4IC totaling $0.05 million. It was determined in March 2003 that this investment should be impaired, as it was evident that IC4IC would not have or be able to raise sufficient equity or debt to fund its operations. During April 2003, IC4ICs Board of Directors made the decision to discontinue operations.
Note 6. Property and Equipment, Net
The components of property and equipment, net at September 30, 2004 and December 31, 2003 are as follows:
Estimated Useful Lives |
September 30, 2004 |
December 31, 2003 |
||||||||
Purchased computer software |
1-3 years | $ | 26,251 | $ | 23,745 | |||||
Computers and equipment |
3-7 years | 13,301 | 12,666 | |||||||
Furniture |
3-7 years | 3,050 | 2,823 | |||||||
Leasehold improvements |
Lease term* | 1,344 | 1,516 | |||||||
Construction in-progress (software and equipment) |
73 | 25 | ||||||||
Gross property and equipment |
44,019 | 40,775 | ||||||||
Less accumulated depreciation and amortization |
(37,662 | ) | (30,513 | ) | ||||||
Property and equipment, net |
$ | 6,357 | $ | 10,262 | ||||||
* | Shorter of estimated useful life or lease term. |
Depreciation and amortization expense related to property and equipment components above was $2.3 million and $2.1 million for the three months ended September 30, 2004 and 2003, respectively and was $7.3 million and $6.5 million for the nine months ended September 30, 2004 and 2003, respectively.
Note 7. Convertible Notes
4.50% Convertible Notes due 2005
In September 2000, the Company issued $460.0 million of 4.50% Convertible Notes due September 12, 2005 (the 4.50% Notes), and received proceeds of $444.0 million, net of debt issuance costs. The 4.50% Notes are convertible, at the option of the holder, at any time on or prior to maturity, into shares of common stock at a conversion price of $61.9225 per share.
On February 11, 2002, the Companys Board of Directors approved a tender offer to purchase up to $200.0 million aggregate principal of the Companys then outstanding 4.50% Notes at a price not greater than $700 nor less than $650 per $1,000 principal amount, plus accrued and unpaid interest thereon to, but not including, the date of the purchase. As a result of this offer, the Company repurchased $199.9 million face value of the then outstanding 4.50% Notes at the price of $700 per $1,000 principal amount for a cash payment of $139.9 million. During 2001, the Company repurchased some of its outstanding 4.50% Notes on the open market.
On September 30, 2003, the Company completed its exchange offer with and new money offering to the holders of the Companys 4.50% Notes with the issuance of 5.45% Convertible Plus Cash NotesSM due September 30, 2007. As of September 30, 2004 and December 31, 2003, the remaining outstanding principal balance of the 4.50% Notes was $24.4 million.
The 4.50% Notes are unsecured and unsubordinated obligations and rank on parity in right of payment with all existing and future unsecured and unsubordinated indebtedness.
5.45% Convertible Plus Cash NotesSM due 2007
On September 30, 2003, the Company completed its exchange offer with and new money offering to holders of the 4.50% Notes. The Company issued $98.0 million aggregate principal amount of 5.45% Convertible Plus Cash NotesSM due September 30, 2007 (the Plus Cash Notes), which represented $74.0 million of Plus Cash Notes issued in exchange for the 4.50% Notes tendered in the exchange offer and $24.0 million of additional Plus Cash Notes sold for cash to holders of existing 4.50% Notes. The net proceeds from the new money offering are being used for general corporate purposes, including working capital and research and development. In the second quarter of 2004, the Company exchanged, in privately negotiated transactions with holders of the Plus Cash Notes pursuant to Section 3(a)(9) of the Securities Act of 1933, as amended, approximately $5.5 million
12
TRANSWITCH CORPORATION AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements
(Tabular dollars in thousands, except share and per share amounts)
in aggregate original principal amount of the Plus Cash Notes for approximately 3.3 million shares of the Companys common stock. No such exchanges were effected in the three months ended September 30, 2004 . Approximately $92.0 million and $97.6 million of the Plus Cash Notes remained outstanding as of September 30, 2004 and December 31, 2003, respectively.
The following description provides a brief overview of the terms and conditions of the Plus Cash Notes. Each Plus Cash Note may be converted by the holders thereof into 182.71 shares of the Companys common stock (the base shares) plus $500 in cash (the plus cash amount), which the Company may elect to pay with shares of its common stock subject to the terms and conditions of the Plus Cash Notes indenture. Interest on the Plus Cash Notes is payable at a rate of 5.45% per year, payable on March 31 and September 30 of each year, commencing on March 31, 2004. The Company may elect to pay interest in cash or common stock, subject to the terms and conditions of the Plus Cash Notes. At any time prior to maturity, the Company may, at its option, elect to automatically convert (an auto-conversion) the Plus Cash Notes if the closing price of its common stock exceeds $5.47 for 20 trading days during any consecutive 25 trading day period, subject to the terms and conditions of the Plus Cash Notes. The Company may elect to satisfy the plus cash amount issuable in connection with any auto-conversion in cash or common stock, subject to the terms and conditions of the Plus Cash Notes. If the Company effects an auto-conversion prior to September 30, 2005, the Company will pay the additional interest that would be payable pursuant to the terms of the Plus Cash Notes, as described under Auto-Conversion Make Whole Provision below in cash.
The notes are unsecured and unsubordinated obligations and rank in parity in right of payment with all existing and future unsecured and unsubordinated indebtedness.
Derivative Liability Related to 5.45% Convertible Plus Cash NotesSM due 2007
In accordance with Statement of Financial Accounting Standards No. 133, Accounting for Derivative Instruments and Hedging Activities, as amended (SFAS 133), the auto-conversion make-whole provision and the holders conversion right (collectively, the features) contained in the terms governing the Plus Cash Notes were not clearly and closely related to the characteristics of the Plus Cash Notes. Accordingly, the features qualified as embedded derivative instruments at issuance and, because they do not qualify for any scope exception within SFAS 133, they are required by SFAS 133 to be accounted for separately from the debt instrument and recorded as derivative financial instruments.
Auto-Conversion Make-Whole Provision
Pursuant to the terms of the Plus Cash Notes, the Company will pay additional interest equal to two full years of interest on the Plus Cash Notes (the auto-conversion make-whole provision), less any interest actually paid or provided for on the Plus Cash Notes if the Plus Cash Notes are automatically converted by the Company on or prior to September 30, 2005. The auto-conversion make-whole provision represents an embedded derivative that is required to be accounted for apart from the underlying Plus Cash Notes. At issuance of the Plus Cash Notes, the auto-conversion make-whole provision had an estimated initial fair value of $3.0 million, which was recorded as a discount to the Plus Cash Notes and a derivative liability on the consolidated balance sheets. The discount on the Plus Cash Notes will be accreted to par value through quarterly interest charges over the four-year term of the Plus Cash Notes. The auto-conversion make-whole provision can only be settled in cash, and accordingly, will remain classified as a derivative liability in the consolidated balance sheets as long as the provision is available. The auto-conversion make-whole provision will be adjusted to its fair value on a quarterly basis for the first two years that any such Plus Cash Notes are outstanding, with the corresponding charge or credit to other expense or income. The estimated fair value of the auto-conversion make-whole provision was determined using the Monte Carlo simulation model. The model uses several assumptions including: historical stock price volatility, risk-free interest rate, remaining maturity, and the closing price of the Companys common stock to determine estimated fair value of the derivative liability. For the three and nine months ended September 30, 2004, the Company recorded other income on the consolidated statements of operations for the change in fair value of the auto-conversion make-whole provision of approximately $0.5 million and $2.1 million, respectively. At September 30, 2004 and December 31, 2003, the estimated fair value of the auto-conversion make-whole provision was approximately $0.1 million and $2.2 million, respectively. The recorded value of the auto-conversion make-whole provision related to the Plus Cash Notes can fluctuate significantly based on fluctuations in the fair value of the Companys common stock and the time remaining of this feature.
Holders Conversion Right
Pursuant to the terms of the Plus Cash Notes, these notes are convertible at the option of the holder, at anytime on or prior to maturity, other than on an auto-conversion date or a redemption date (Holders Conversion Right). The Holders Conversion Right represents an embedded derivative that is required to be accounted for apart from the underlying Plus Cash Notes. At
13
TRANSWITCH CORPORATION AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements
(Tabular dollars in thousands, except share and per share amounts)
issuance of the Plus Cash Notes, the Holders Conversion Right had an estimated initial fair value of $20.3 million, which was recorded as a discount to the Plus Cash Notes and a derivative liability on the consolidated balance sheets. The discount on the Plus Cash Notes will be accreted to par value through quarterly interest charges over the four-year term of the Plus Cash Notes. Assuming the daily volume weighted average price determined according to the voluntary conversion provision in the Plus Cash Notes indenture is or remains below the threshold price of $2.61, the derivative related to the Holders Conversion Right will be adjusted quarterly for changes in fair value during the period of time that any such Plus Cash Notes are outstanding and classified as a derivative liability, with the corresponding charge or credit to other expense or income. In subsequent periods, if the daily volume weighted average price of the Companys common stock determined according to the voluntary conversion provision equals or exceeds the threshold price of $2.61, the embedded derivative financial instrument related to the Holders Conversion Right will be adjusted to fair value with the corresponding charge or credit to other expense or income and then reclassified from total liabilities to stockholders equity. Changes in fair value during the period of time that any such Plus Cash Notes are outstanding and classified within stockholders equity, will be made by a corresponding charge or credit to additional paid-in-capital. The estimated fair value of the Holders Conversion Right was determined using the Black-Scholes option-pricing model. The model uses several assumptions including: historical stock price volatility, risk-free interest rate, remaining maturity, and the closing price of the Companys common stock to determine estimated fair value of the derivative liability. For the three and nine months ended September 30, 2004, the Company recorded other income on the consolidated statements of operations for the change in fair value of the Holders Conversion Right of approximately $4.6 million and $10.8 million, respectively. At September 30, 2004 and December 31, 2003, the estimated fair value of the Holders Conversion Right was approximately $7.7 million and $18.5 million, respectively. The recorded value of the Holders Conversion Right related to the Plus Cash Notes can fluctuate significantly based on fluctuations in the fair value of the Companys common stock.
For the three and nine months ended September 30, 2004, the Company amortized $1.4 million and $4.2 million, respectively of debt discount related to the Plus Cash Notes as discussed above.
Exchanges of the Plus Cash Notes for Shares of Common Stock
During the nine months ended September 30, 2004, the Company issued an aggregate of 3,278,940 shares of the Companys common stock plus approximately $0.06 million cash in lieu of accrued and unpaid interest in exchange for $5.5 million in aggregate original principal amount of the Plus Cash Notes. The shares issued were exempt from registration pursuant to Section 3(a)(9) of the Securities Act of 1933, as amended. No commission or other remuneration was paid or given directly or indirectly for soliciting these transactions. As a result of the exchange, the Company incurred a non-cash loss of approximately $1.2 million due to the write-off of the unamortized debt discount and deferred financing costs related to the exchanged Plus Cash Notes. The Company did not effect any such exchanges during the three months ended September 30, 2004.
Note 8. Supplemental Cash Flow Information
The following represents supplemental cash flow information for the nine months ended September 30, 2004 and 2003:
Nine Months Ended September 30, | ||||||
2004 |
2003 | |||||
Cash paid for interest |
$ | 6,264 | $ | 5,135 | ||
The following represents a supplemental schedule of non-cash investing and financing activities: |
||||||
Conversion of 5.45% Plus Cash Notes into Common stock |
$ | 5,489 | |
Note 9. Shelf Registration
On April 6, 2004, the Company filed a shelf registration statement on Form S-3 (Registration No. 333-114238) with the Securities and Exchange Commission (SEC) providing for the offer, from time to time, of common stock, preferred stock, debt securities and warrants up to an aggregate of $60.0 million. On April 19, 2004, the SEC declared effective the shelf registration statement. This enables the Company to, at any time in the subsequent two-year period, make an offering of any individual security covered by the shelf registration statement as well as any combination thereof, subject to market conditions and the Companys capital needs. The Company may use the net proceeds from the sale of these securities for general corporate purposes, which may include repayment or refinancing of existing indebtedness, acquisitions, investments, capital expenditures, repurchase of its capital stock and for any other purposes that the Company may specify in any prospectus supplement.
14
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
Managements Discussion and Analysis of Financial Conditions and Results of Operations (MD&A) is provided as a supplement to the accompanying unaudited consolidated financial statements and footnotes in Item 1 to help provide an understanding of our financial condition, changes in our financial condition and results of operations. The MD&A is organized as follows:
Caution concerning forward-looking statements. This section discusses how certain forward-looking statements made by us throughout this Quarterly Report on Form 10-Q and any documents incorporated by reference into this Quarterly Report on Form 10-Q are based on managements present expectations about future events and are inherently susceptible to uncertainty and changes in circumstances.
Overview. This section provides a general description of our business.
Critical accounting policies and use of estimates. This section discusses those accounting policies that are both considered important to our financial condition and operating results and require significant judgment and estimates on the part of management in their application.
Results of operations. This section provides an analysis of our results of operations for the three and nine months ended September 30, 2004 and 2003. In addition, a brief description is provided of transactions and events that impact the comparability of the results being analyzed.
Liquidity and capital resources. This section provides an analysis of our cash position and cash flows as well as a discussion of our financing arrangements. In this section, we also summarize related party transactions and recent accounting pronouncements.
Factors that may affect future results. In this section, we detail certain risk factors that affect our quarterly and annual results, but which are difficult to predict.
CAUTION CONCERNING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains, and any documents incorporated herein by reference may contain, forward-looking statements that involve risks and uncertainties. When used in this document, the words, intend, anticipate, believe, estimate, plan, expect and similar expressions as they relate to us are included to identify forward-looking statements. Our actual results could differ materially from the results discussed in the forward-looking statements as a result of risk factors including those set forth under FACTORS THAT MAY AFFECT FUTURE RESULTS and elsewhere in this report. You should read this discussion in conjunction with the accompanying unaudited consolidated financial statements and the notes thereto included in this report.
OVERVIEW
We are a Delaware corporation incorporated on April 26, 1988. We design, develop and market highly integrated semiconductor devices, also referred to as very large scale integration (VLSI) devices that provide core functionality in voice and data communications network equipment deployed in the global network infrastructure. In addition to their high degree of functionality, our products incorporate digital and mixed-signal (analog and digital) processing capabilities, providing comprehensive system-on-a-chip (SOC) solutions to our customers.
Our products are compliant with all relevant communications network standards including Asynchronous/Plesiochronous Digital Hierarchy (Asynchronous/PDH), Synchronous Optical Network/Synchronous Digital Hierarchy (SONET/SDH), Ethernet and Asynchronous Transfer Mode/Internet Protocol (ATM/IP). We offer several products that combine multi-protocol capabilities on a single chip, enabling our customers to develop network equipment for multi-service (voice, data and video) applications. A key attribute of our products is their inherent flexibility. Many of our products incorporate embedded programmable micro-processors, enabling us to rapidly accommodate new customer requirements or evolving network standards by modifying a function of the device via software instruction.
We bring value to our customers through our communications systems expertise, VLSI design skills and commitment to excellence in customer support. Our emphasis on technical innovation and complete reference solutions enable us to define and develop products that permit our customers to achieve faster time-to-market, and to produce communications systems that offer a host of benefits such as greater functionality, improved performance, lower power dissipation, reduced system size and cost, and greater reliability for their customers.
After several years of rapid growth, the global telecommunications industry experienced a severe downturn beginning in 2001. In response to this downturn, we have taken steps to restructure our operations and reduce operating costs. However, we have continued to invest in the design and development of future products, which we believe is vital to maintain a competitive edge. As a result, since 2001, the Company has posted significant operating losses.
15
Our markets stabilized in 2003 and we believe that we are now in the early stages of a market recovery. For the nine months ended September 30, 2004, our revenues are up $8.9 million or 54% over the same period last year, reflecting this strengthening in demand. As our markets continue to strengthen, we believe that our investment in product development has positioned us to take advantage of this recovery.
Available Information
Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and all amendments to those reports will be made available free of charge through the Investor Relations section of the Companys Internet website (http://www.transwitch.com) as soon as practicable after such material is electronically filed with, or furnished to, the Securities and Exchange Commission. Material contained on our website is not incorporated by reference in this report. Our executive offices are located at Three Enterprise Drive, Shelton, CT 06484.
16
CRITICAL ACCOUNTING POLICIES AND USE OF ESTIMATES
Our unaudited consolidated financial statements and related disclosures, which are prepared to conform with accounting principles generally accepted in the United States of America (U.S. GAAP), require us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses during the period reported. We are also required to disclose amounts of contingent assets and liabilities at the date of the consolidated financial statements. Our actual results in future periods could differ from those estimates and assumptions. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary.
We consider the most critical accounting policies and uses of estimates in our unaudited consolidated financial statements to be those surrounding:
(1) | net revenues, cost of revenues and gross profit; |
(2) | derivative liability associated with our 5.45% Convertible Plus Cash NotesSM due 2007; |
(3) | estimated excess and obsolete inventories; |
(4) | estimated restructuring reserves; and |
(5) | valuation of investments in non-publicly traded companies. |
These accounting policies, the bases for these estimates and their potential impact to our unaudited consolidated financial statements, should any of these estimates change, are further described as follows:
Net Revenues, Cost of Revenues and Gross Profit. Net revenues are primarily comprised of product shipments, principally to domestic and international telecommunications and data communications Original Equipment Manufacturers (OEMs) and to distributors. Net revenues from product sales are recognized at the time of product shipment when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) title and risk of loss transfers to the customer; (3) the selling price is fixed or determinable; and (4) collectibility is reasonably assured. Agreements with certain distributors provide price protection and return and allowance rights. With respect to recognizing revenues from our distributors: (1) the prices are fixed at the date of shipment from our facilities; (2) payment is not contractually or otherwise excused until the product is resold; (3) we do not have any obligations for future performance relating to the resale of the product; and (4) the amount of future returns, allowances, refunds and costs to be incurred can be reasonably estimated and are accrued at the time of shipment. Service revenues are recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) we have performed a service in accordance with our contractual obligations; (3) the fee is fixed or determinable; and (4) collectibility is reasonably assured.
At the time of shipment, we record an expense (and related liability) against our gross product revenues for future price protection. This liability is established based on historical experience and contractually agreed to provisions. We had established liabilities totaling $0.4 million and $0.7 million as of September 30, 2004 and December 31, 2003, respectively, for price protection and sales allowances related to shipments that were recorded as revenue during the preceding twelve months. Should our actual experience differ from our estimated liabilities, there could be adjustments (either favorable or unfavorable) to our net revenues, cost of revenues and gross profits.
We also record, at the time of shipment, an expense (and related liability) against our gross product revenues and an inventory asset against product cost of revenues in order to establish a provision for the gross margin related to future returns under our distributor stock rotation program. As of September 30, 2004, we had established a liability of $0.5 million against our gross product revenues and an inventory asset of $0.2 million against our product cost of revenues for a net stock rotation reserve of $0.3 million. This compares to a liability of $1.0 million and an inventory asset of $0.5 million for a net stock rotation reserve of $0.5 million as of December 31, 2003. Should our actual experience differ from our estimated liabilities, there could be adjustments (either favorable or unfavorable) to our net revenues, cost of revenues and gross profits.
We warranty our products for up to one year from the date of shipment. A liability is recorded for estimated claims to be incurred under product warranties and is based primarily on historical experience. Estimated warranty expense is recorded as cost of product revenues when products are shipped. As of September 30, 2004 and December 31, 2003, we had a warranty liability established in the amounts of $0.3 million and $0.3 million, respectively, which is included in accrued expenses and other current liabilities on the consolidated balance sheets. We had no material warranty claims during the nine months ended September 30, 2004. Should future warranty claims differ from our estimated current liability, there could be adjustments (either favorable or unfavorable) to our cost of revenues. Any adjustments to cost of revenues could also impact future gross profits.
17
Derivative LiabilityAssociated with our 5.45% Convertible Plus Cash NotesSM due 2007. In accordance with Statement of Financial Accounting Standards No. 133, Accounting for Derivative Instruments and Hedging Activities, as amended (SFAS 133), the auto-conversion make-whole provision and the holders conversion right (collectively, the Features) contained in the terms governing our 5.45% Convertible Plus Cash NotesSM due 2007 (the Plus Cash Notes) were not clearly and closely related to the characteristics of the Plus Cash Notes upon issuance. Accordingly, the Features qualified as embedded derivative instruments and, because they do not qualify for any scope exception within SFAS 133, they are required by SFAS 133 to be accounted for separately from the debt instrument and recorded as derivative financial instruments.
During the three months ended September 30, 2004, we recorded other income of $5.1 million of which $0.5 million relates to the auto-conversion make-whole provision and $4.6 million relates to the holders conversion right, to reflect the change in fair value of our derivative liability, which is calculated below:
(Tabular dollars in thousands, except per share data) | September 30, 2004 |
December 31, 2003 | ||||
Closing price of our common stock used to value our derivative liability |
$ | 1.26 | $ | 2.30 | ||
Estimated fair value of our derivative liability |
$ | 7,807 | $ | 20,659 | ||
Change in fair value of our derivative liability recorded as other income during the period |
$ | 5,126 | $ | 2,619 |
At each balance sheet date, we adjust the derivative financial instruments to their estimated fair value and analyze the holders conversion right to determine its classification as a liability or equity. As of September 30, 2004, the estimated fair value of our derivative liability was $7.8 million, of which $0.1 million and $7.7 million related to the auto-conversion make-whole provision and holders conversion right, respectively. As of December 31, 2003, the estimated fair value of our derivative liability was $20.7 million, of which $2.2 million and $18.5 million related to the auto-conversion make-whole provision and holders conversion right, respectively. The estimated fair value of the auto-conversion make-whole provision and holders conversion right were determined using the Monte Carlo simulation model and the Black-Scholes option-pricing model, respectively. These models use several assumptions including: historical stock price volatility, risk-free interest rates, remaining maturity, and the closing price of our common stock to determine estimated fair value of our derivative liability. We believe that the assumption that has the greatest impact on the determination of fair value is the closing price of our common stock during each quarterly period. Accordingly, we have calculated the fair value of the derivative liability as shown in the following different scenarios. We have included the change in the fair value of the derivative liability below based on all assumed estimates remaining the same except for our common stock price.
% change from our actual common stock price of $1.26 as of September 30, 2004 |
||||||||||||||||||||||||
(Tabular dollars in thousands, except per share data) | ||||||||||||||||||||||||
% change from our actual common stock price of $1.26 as of September 30, 2004 |
(50)% | (25)% | (10)% | Actual | 10% | 25% | 50% | |||||||||||||||||
Closing price of our common stock used to value our derivative liability |
$ | 0.63 | $ | 0.95 | $ | 1.13 | $ | 1.26 | $ | 1.39 | $ | 1.58 | $ | 1.89 | ||||||||||
Estimated fair value of our derivative liability as of September 30, 2004 |
$ | 2,885 | $ | 5,261 | $ | 6,715 | $ | 7,807 | $ | 8,913 | $ | 10,607 | $ | 13,420 | ||||||||||
Change in fair value of our derivative liability determined during the third quarter of 2004 and recorded as other income (expense) |
$ | 10,049 | $ | 7,673 | $ | 6,219 | $ | 5,126 | $ | 4,021 | $ | 2,327 | $ | (486 | ) | |||||||||
Incremental other income (expense) that would have been recorded in third quarter of 2004 |
$ | 4,923 | $ | 2,547 | $ | 1,093 | $ | | $ | (1,105 | ) | $ | (2,799 | ) | $ | (5,612 | ) | |||||||
As of September 30, 2004 and December 31, 2003, these embedded derivative financial instruments were recorded and classified as a derivative liability on our consolidated balance sheets because the daily volume weighted average price of our common stock determined according to the voluntary conversion provision contained in the Plus Cash Notes indenture was below the threshold price of $2.61 as set forth in the terms of the Plus Cash Notes. Thus, if any holders of the Plus Cash Notes voluntarily converted their Plus Cash Notes, we would have to pay the plus cash amount in cash. Assuming the daily volume weighted average price of our common stock remains below the threshold price, this embedded derivative related to the holders conversion right will continue to be classified as a liability and adjusted quarterly for changes in fair value during the period of time that any such Plus Cash Notes are outstanding, with the corresponding charge or credit to other expense or income.
18
In subsequent periods, if the daily volume weighted average price of our common stock determined according to the voluntary conversion provision equals or exceeds the threshold price of $2.61, the embedded derivative financial instrument related to the holders conversion right will be adjusted to fair value with the corresponding charge or credit to other expense or income and then reclassified from total liabilities to stockholders equity. Changes in fair value during the period of time that any such Plus Cash Notes are outstanding and classified within stockholders equity will be made by a corresponding charge or credit to additional paid-in-capital. The auto-conversion make-whole provision will be adjusted quarterly for changes in fair value during the first two years that any such Plus Cash Notes are outstanding, with the corresponding charge or credit to other expense or income. The auto-conversion make-whole provision can only be settled with cash and, accordingly, will remain classified as a derivative liability on our consolidated balance sheets.
Estimated Excess Inventories. We periodically review our inventory levels to determine if inventory is stated at the lower of cost or net realizable value. The telecommunications and data communications industries have experienced a significant downturn during the past few years and, as a result, we have had to evaluate our inventory position based on known backlog of orders, projected sales and marketing forecasts, shipment activity and inventory held at our significant distributors. During the three months ended September 30, 2004 and 2003, we recorded charges for excess and obsolete inventories of approximately $0.6 million and zero, respectively. During the nine months ended September 30, 2004 and 2003, we recorded charges for excess and obsolete inventories of approximately $0.6 million and $1.5 million, respectively. We also recorded excess inventory charges totaling $1.5 million, $4.8 million and $39.2 million in fiscals 2003, 2002 and 2001, respectively. Most of these products have not been disposed of and remain in our inventory
During the three months ended September 30, 2004 and 2003, we recorded net product revenues of approximately $2.7 million and $1.8 million, respectively, on shipments of excess inventory that had previously been written down to their estimated net realizable value of zero. This resulted in gross margin of approximately 100% on these product revenues. Had these products been sold at our historical average cost basis, a 58% and 61% gross margin would have been recorded on these product shipments for the three months ended September 30, 2004 and 2003, respectively. During the nine months ended September 30, 2004 and 2003, we recorded net product revenues of approximately $8.9 million and $6.2 million, respectively, on shipments of excess inventory that had previously been written down to their estimated net realizable value of zero. This resulted in gross margin of approximately 100% on these product revenues. Had these products been sold at our historical average cost basis, a 59% and 53% gross margin would have been recorded on these product shipments for the nine months ended September 30, 2004 and 2003, respectively. We currently do not anticipate that a significant amount of the excess inventories subject to the write-downs described above will be used in the future based upon our current demand forecast. Should our actual future demand exceed the estimates that we used in writing down our excess inventories, we will recognize a favorable impact to cost of revenues and gross profits. Should demand fall below our current expectations, we may record additional inventory write-downs which will result in a negative impact to cost of revenues and gross profits.
Estimated Restructuring Reserves. During the three months ended September 30, 2004, the Company recorded restructuring charges totaling $0.5 million resulting from the Companys liquidation of its investment in TeraOp (USA), Inc. (TeraOp) and the wind-down of the business and operations of OptiX Networks, Inc. (OptiX), two Israeli development stage companies consolidated in the Companys financial statements under FIN 46R. In the nine months ended September 30, 2004, restructuring charges totaled $0.3 million, reflecting the charges totaling $0.5 million for TeraOp and OptiX, partially offset by changes in the estimated fair value of the liability for future excess facility costs recorded in 2003. During the nine months ended September 30, 2003, we recorded a restructuring charge and asset impairments totaling $3.1 million, related to costs for employee termination benefits and costs to exit certain facilities, net of sub-lease benefits. We also recorded restructuring charges and asset impairments totaling $2.5 million, $3.9 million and $34.2 million in fiscal years ended December 31, 2003, 2002 and 2001, respectively. At September 30, 2004 and December 31, 2003, the restructuring liabilities were $23.0 million and $24.1 million, respectively, on our consolidated balance sheets. Certain assumptions are used by us to derive this estimate, including future maintenance costs, price escalation and sublease income derived from these facilities. Should we negotiate additional sublease rental income agreements or reach a settlement with our lessors to be released from our existing obligations, we could realize a favorable benefit to our results of future operations. Should future lease, maintenance or other costs related to these facilities exceed our estimates, we could incur additional expenses in future periods.
Valuation of Investments in Non-Publicly Traded Companies. Since 1999, we have been making strategic equity investments in non-publicly traded companies that develop technologies that are complementary to our product road map. We initially evaluate each investment to determine whether a variable interest has been created in a variable interest entity and whether we then should consolidate our investment according to the provisions of FIN 46 (revised December 2003),
19
Consolidation of Variable Interest Entities (FIN 46R). Depending on the facts and circumstances surrounding each investment, we make a determination as to the consolidation of the investment based on the specific requirements of FIN 46R. If we conclude that consolidation of the investment is not appropriate, then we evaluate each investment based on our level of ownership and whether or not we have the ability to exercise significant influence over the investee company. As a result of this evaluation, we then account for these investments on either the cost or equity method, and review such investments periodically for impairment. The appropriate reductions in carrying values are recorded when, and if, necessary. The process of assessing whether a particular investments net realizable value is less than its carrying cost requires a significant amount of judgment. In making this judgment, we carefully consider the investees cash position, projected cash flows (both short- and long-term), financing needs, most recent valuation data, the current investing environment, management / ownership changes and competition. This evaluation process is based on information that we request from these privately-held companies. This information is not subject to the same disclosure and audit requirements as the reports required of U.S. public companies, and as such, the reliability and accuracy of the data may vary. Based on our evaluations, we recorded impairment charges related to our investments in non-publicly traded companies of $0.1 million and $0.05 million during the nine months ended September 30, 2004 and 2003, respectively. We did not record any such impairment charges during the three months ended September 30, 2004 and 2003. We used the modified equity method of accounting to determine the impairment loss for certain investments, as it was determined that no better current evidence of the value of our cost method investments existed and we believe that this gives us the best basis for our estimate given the negative cash flows of these companies. The modified equity method of accounting results in recording an impairment loss for a cost method investment equal to the investors proportionate share of the investees losses as its contributed capital is consumed to fund operating losses of the investee from the inception of the investors investment.
RESULTS OF OPERATIONS
The results of operations that follow should be read in conjunction with our critical accounting policies and use of estimates summarized above as well as our accompanying unaudited consolidated financial statements and notes thereto contained in Item 1 of this report. The following table sets forth certain unaudited interim consolidated statements of operations data as a percentage of net revenues for the periods indicated.
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||
2004 |
2003 |
2004 |
2003 |
|||||||||
Net revenues: |
||||||||||||
Product revenues |
100 | % | 93 | % | 99 | % | 96 | % | ||||
Service revenues |
0 | % | 7 | % | 1 | % | 4 | % | ||||
Total net revenues |
100 | % | 100 | % | 100 | % | 100 | % | ||||
Cost of revenues: |
||||||||||||
Product cost of revenues |
30 | % | 26 | % | 27 | % | 27 | % | ||||
Provision for excess inventories |
7 | % | | 2 | % | 9 | % | |||||
Service cost of revenues |
0 | % | 2 | % | 1 | % | 1 | % | ||||
Total cost of revenues |
37 | % | 28 | % | 30 | % | 38 | % | ||||
Gross profit |
63 | % | 72 | % | 70 | % | 62 | % | ||||
Operating expenses: |
||||||||||||
Research and development and purchased in-process research and development |
135 | % | 196 | % | 146 | % | 194 | % | ||||
Marketing and sales |
33 | % | 49 | % | 37 | % | 50 | % | ||||
General and administrative |
18 | % | 24 | % | 20 | % | 25 | % | ||||
Restructuring charge (benefit) and asset impairments, net |
6 | % | (15 | )% | 1 | % | 19 | % | ||||
Total operating expenses |
192 | % | 254 | % | 205 | % | 288 | % | ||||
Operating loss |
(129 | )% | (182 | )% | (135 | )% | (226 | )% | ||||
20
Net Revenues
The following tables summarizes our net product revenue mix by product line for the three and nine months ended September 30, 2004 and 2003:
Three Months Ended September 30, 2004 |
Three Months Ended September 30, 2003 |
Percentage Increase in Product |
|||||||||||||
Tabular dollars in thousands | Product Revenues |
Percent of Product Revenues |
Product Revenues |
Percent of Product Revenues |
|||||||||||
SONET/SDH |
$ | 4,102 | 49 | % | $ | 2,869 | 54 | % | 43 | % | |||||
Asynchronous/PDH |
2,629 | 32 | % | 874 | 17 | % | 201 | % | |||||||
ATM/IP |
1,605 | 19 | % | 1,521 | 29 | % | 6 | % | |||||||
Total |
$ | 8,336 | 100 | % | $ | 5,264 | 100 | % | 58 | % | |||||
Nine Months Ended September 30, 2004 |
Nine Months Ended September 30, 2003 |
Percentage in Product |
|||||||||||||
Tabular dollars in thousands | Product Revenues |
Percent of Product Revenues |
Product Revenues |
Percent of Product Revenues |
|||||||||||
SONET/SDH |
$ | 12,100 | 48 | % | $ | 5,727 | 36 | % | 111 | % | |||||
Asynchronous/PDH |
5,637 | 23 | % | 2,633 | 17 | % | 114 | % | |||||||
ATM/IP |
7,303 | 29 | % | 7,351 | 47 | % | (1 | )% | |||||||
Total |
$ | 25,040 | 100 | % | $ | 15,711 | 100 | % | 59 | % | |||||
The increase in net revenues for the three and nine months ended September 30, 2004 compared to the same periods in 2003 is primarily due to increased volume shipments in our SONET/SDH and Asynchronous/PDH product lines. The increase in volume in these product lines can be attributed to overall increased demand as well as inventory depletion in the distribution channel. As inventory is being consumed, customers are placing new orders to meet their end demand.
Included in total net revenues were service revenues consisting of design services performed for third parties on a short-term contract basis. Service revenues are not our primary strategic focus and, as such, will fluctuate up or down from period to period, depending on business priorities.
International net revenues represented approximately 60% and 61% of net revenues for the three and nine months ended September 30, 2004, respectively, compared with approximately 60% and 68% of net revenues for the three and nine months ended September 30, 2003, respectively.
Gross Profit
The following tables present the favorable impact to gross profit from the sale of previously written down inventory for the three and nine months ended September 30, 2004 and 2003:
Three Months Ended September 30, 2004 |
Three Months Ended September 30, 2003 |
|||||||||||||
Tabular dollars in thousands | Gross Profit $ |
Gross Profit % |
Gross Profit $ |
Gross Profit % |
||||||||||
TGross profit as reported |
$ | 5,277 | 63 | % | $ | 4,073 | 72 | % | ||||||
Excess inventory benefit(1) |
(1,025 | ) | (12 | )% | (602 | ) | (11 | )% | ||||||
Excess inventory charge(2) |
571 | 7 | % | | | % | ||||||||
Gross profit as adjusted |
$ | 4,823 | 58 | % | $ | 3,471 | 61 | % | ||||||
Nine Months Ended September 30, 2004 |
Nine Months Ended September 30, 2003 |
|||||||||||||
Tabular dollars in thousands | Gross Profit $ |
Gross Profit % |
Gross Profit $ |
Gross Profit % |
||||||||||
Gross profit as reported |
$ | 17,619 | 70 | % | $ | 10,167 | 62 | % | ||||||
Excess inventory benefit(1) |
(3,178 | ) | (13 | )% | (2,948 | ) | (18 | )% | ||||||
Excess inventory charge(2) |
571 | 2 | % | 1,498 | 9 | % | ||||||||
Gross profit as adjusted |
$ | 15,012 | 59 | % | $ | 8,717 | 53 | % | ||||||
(1) | During the three and nine months ended September 30, 2004 and 2003, we realized an excess inventory benefit from the sale of products that had previously been written down to a cost basis of zero. For the purposes of comparing the change in gross profit on net revenues, we are excluding this benefit and calculating gross profit on these product revenues as if they had been sold at their historical average costs. |
(2) | We recorded excess and obsolete inventory charges totaling $0.6 million and zero for the three months ended September 30, 2004 and 2003, respectively. We recorded excess and obsolete inventory charges totaling $0.6 million and $1.5 million for the nine months ended September 30, 2004 and 2003, respectively. |
21
Total gross profit for the three months ended September 30, 2004 increased by approximately $1.2 million, or 30% from the comparable three months of the prior year, while gross profit for the nine months ended September 30, 2004 increased by approximately $7.5 million, or 73% as compared with the same period in 2003. The increase in gross profit reflects increased revenues and a more favorable product mix. Excluding the benefit from sales of previously written down inventory and the impact of excess and obsolete inventory charges, for the three and nine months ended September 30, 2004, gross profit increased by approximately $1.4 million, or 39% and $6.3 million, or 72%, respectively. The fluctuations in gross profit margins are due to changes in the product mix over the prior year and do not indicate a shift in our margin trend, either positive or negative.
We anticipate that gross profit will continue to be impacted by fluctuations in the volume and mix of our product shipments as well as material costs, yield and the fixed cost absorption of our product operations.
Research and Development
Research and development expenses were $11.2 million for the three months ended September 30, 2004, an increase of $0.1 million or 1% over same prior year period. This increase reflects the consolidation of OptiX expenses in 2004, partially offset by a charge in 2003 for purchased in-process research and development.
For the nine months ended September 30, 2004, research and development expenses increased $5.0 million, or 16% over the comparable period of 2003 due to increased spending on subcontracting, consulting and fabrication, as well as the consolidation of OptiX expenses in 2004. During the first half of 2004, we retained additional external resources to complete new product development projects and meet customer requirements. In the third quarter of 2004, we took several steps to reduce our research and development expenses. These steps included the decision to discontinue further funding of OptiX, as well as the decision to liquidate our investment in TeraOp, two Israeli development stage companies consolidated in the Companys financial statements under the rules of FIN 46R. We are also exploring alternatives to disengage from our Belgian design center, which could further reduce our expenses. In addition, in the third quarter of 2004, we reduced our subcontractor expenses by approximately $0.6 million from the second quarter of 2004. As a percentage of total net revenues, our research and development costs decreased as we have experienced an increase in our total net revenues for the three and nine months ended September 30, 2004 as compared to the same periods in the prior year.
We believe that continued investment in the design and development of future products is vital to maintain a competitive edge. However, we have monitored our known and forecasted revenue demand and operating expense run rates closely. As a result, in 2004 we commenced the restructuring actions described above and we continue to seek opportunities to further reduce our research and development expenses. We also took two restructuring actions in fiscal 2001, one during fiscal 2002 and one during fiscal 2003. We will continue to closely monitor both our costs and our revenue expectations in future periods. We will continue to balance our spending in this area with meeting our customer requirements and will take actions as market conditions dictate.
Marketing and Sales
Marketing and sales expenses consist primarily of personnel-related expenses, trade show expenses, travel expenses and facilities expenses. Marketing and sales expenses remained flat for the three months ended September 30, 2004 as compared to the same period in the prior year. During the nine months ended September 30, 2004, marketing and sales expense increased $1.2 million, or 14% as compared to the same period in the prior year. The increase is primarily due to increased commissions as a result of improved revenues in 2004. As a percentage of total net revenues, our marketing and sales costs decreased as we continue to monitor our discretionary spending as well as experience an increase in our total net revenue for the three and nine months ended September 30, 2004 as compared to the same periods in the prior year.
We have monitored our known and forecasted sales demand and operating expense run rates closely and, as a result, have taken four restructuring actions since June 2001. We will continue to closely monitor both our costs and our revenue expectations in future periods and will take actions as market conditions dictate. There can be no assurances that future acquisitions, market conditions or unforeseen events will not cause our expenses to rise or fall in future periods.
22
General and Administrative
General and administrative expenses consist primarily of personnel-related expenses, professional and legal fees and facilities expenses. The increase in general and administrative expenses of approximately $0.1 million, or 10% and $1.1 million, or 26% for the three and nine months ended September 30, 2004 compared to the same periods in the prior year is primarily due to increased professional service fees, including expenses required to comply with regulations mandated by the Sarbanes-Oxley Act of 2002, legal and auditing fees. As a percentage of total net revenues, our general and administrative sales costs decreased as we continue to monitor our discretionary spending as well as experience an increase in our total net revenues for the three and nine months ended September 30, 2004 as compared to the same prior year periods.
We have monitored our known and forecasted revenue demand and operating expense run rates closely and, as a result, have taken four restructuring actions since June 2001. We will continue to closely monitor both our costs and our revenue expectations in future periods. We will continue to balance our spending in this area with meeting our customer requirements and will take actions as market conditions dictate.
Restructuring Charge (Benefit) and Asset Impairments, net
During the three months ended September 30, 2004, we recorded restructuring charges totaling $0.5 million resulting from our liquidation of our investment in TeraOp and the wind-down of the business and operations of OptiX, two Israeli development stage companies consolidated in the Companys financial statements under FIN 46R.
In July 2004, we informed OptiX that we planned to discontinue our ongoing funding of OptiXs operations. Consequently, the OptiX Board of Directors voted to wind-down its business and operations. OptiX expects to have the wind-down completed and to permanently close its operations by December 31, 2004. In the three months ended September 30, 2004, we recorded a provision of $0.2 million related to the wind-down of OptiX, of which $0.1 million was to reserve for severance costs and $0.1 million was to record the impairment of certain OptiX assets. We expect to record additional charges in the fourth quarter of 2004 for severance and lease buy-out costs. Upon the completion of the wind-down, OptiX will be deconsolidated from the Companys financial statements.
In September 2004, we entered an agreement with TeraOp under which we converted our promissory notes issued and payable by TeraOp into shares of TeraOp common stock. We then sold all of our common share holdings in TeraOp to an independent third party for a nominal amount. In addition, we paid TeraOp $0.3 million for a royalty on future revenues of TeraOp. Currently, TeraOp has no revenue and may never have revenue in the future. As a result of these transactions, we no longer hold any equity or debt interest in TeraOp and have no influence over the operations of TeraOp. Accordingly, TeraOp was deconsolidated from our financial statements upon the completion of these transactions, resulting in a net restructuring charge of $0.2 million.
In the nine months ended September 30, 2004, restructuring charges totaled $0.3 million, reflecting the charges totaling $0.5 million resulting from our liquidation of our investment in TeraOp and the wind-down of the business and operations of OptiX, partially offset by changes in the estimated fair value of the liability for future excess facility costs recorded in 2003.
In January 2003, we announced a restructuring plan in order to lower our operating expense run-rate due to then current and anticipated business conditions. This plan resulted in a work-force reduction of approximately 24% of existing personnel. Also, we announced the closing of our South Brunswick, New Jersey (SOSi) design center, and the reduction of staff in Bedford, Massachusetts and Shelton, Connecticut. This workforce reduction also impacted our Switzerland and Belgium locations. In addition, we postponed the completion of the Integrated Access Device (IAD) product line and archived the related intellectual property until that market returns, if ever. During the three months ended September 30, 2004, we recorded a restructuring charge totaling $0.1 million related to adjusting previous estimates of the sub-lease of excess facilities. During the nine months ended September 30, 2004, we recorded a restructuring benefit totaling $0.1 million related to the sub-lease of excess facilities. During the three months ended September 30, 2003, we recorded approximately $0.9 million in restructuring benefits primarily related to the adjustment of previous estimates of excess facility costs. During the nine months ended September 30, 2003, we incurred approximately $3.4 million in restructuring expenses related to employee termination benefits and $0.5 million related to excess facility costs. In addition, we determined that fixed assets with a net book value totaling $0.3 million and a patent on our IAD product line with a net book value of $0.2 million were impaired for the nine months ended September 30, 2003. This resulted in a total restructuring charge and asset impairment for the nine months ended September 30, 2003 of $4.4 million. This restructuring charge was partially off-set by a benefit of $1.3 million for the nine months ended September 30, 2003 as we were able to sub-lease portions of our excess facilities, for a net restructuring expense for the nine months ended September 30, 2003 of $3.1 million. We estimate that there will be future adjustments to our liability for future lease payments as market conditions change.
23
During the three months ended September 30, 2004, we began the process of exploring alternatives to disengage from our research and development subsidiary in Belgium. Alternatives under consideration include permanent closure of the unit as well as the sale of all or part of the unit. At this time, we are in the early stages of this evaluation process and have not committed to any plan.
Impairment of Investments in Non-Publicly Traded Companies
For the nine months ended September 30, 2004 and 2003, as a result of industry conditions, we determined that there were indicators of impairment to the carrying value of our investments in non-publicly traded companies. The process of assessing whether a particular investments net realizable value is less than its carrying cost requires a significant amount of judgment. In making this judgment, we carefully consider the investees cash position, projected cash flows (both short- and long-term), financing needs, most recent valuation data, the current investing environment, management / ownership changes, and competition. This evaluation process is based on information that we request from these privately-held companies. This information is not subject to the same disclosure and audit requirements as the reports required of U.S. public companies, and as such, the reliability and accuracy of the data may vary.
During the three and nine months ended September 30, 2004 and 2003, we used the modified equity method of accounting to measure the impairment loss for our investments in Accordion and Intellectual Capital for Integrated Circuits, Inc. (IC4IC), as we determined that no better current evidence of the value of its cost method investments existed. We believe that this measurement process gives us the best basis for our estimate given the negative cash flows of these companies. The modified equity method of accounting results in recording an impairment loss on a cost method investment equal to the investors proportionate share of the investees losses as its contributed capital is consumed to fund operating losses of the investee from the inception of the investors investment.
In addition, we also evaluated all outstanding bridge loans under SFAS 114, Accounting by Creditors for Impairment of a Loan (SFAS 114) that we had not already impaired under the modified equity method of accounting. Under SFAS 114, a loan is considered impaired, based on current information and events, if it is probable that we will be unable to collect the scheduled payments of principal or interest when due according to the contractual terms of the loan agreement.
The measurement of impaired loans is generally based on the present value of expected future cash flows discounted at the historical effective interest rate, except that all collateral-dependent loans are measured for impairment based on the fair value of the collateral.
During the first quarter of 2004, we impaired our remaining investments in convertible debt in Accordion Networks, Inc. (Accordion) based on review of impairment indicators listed above. In addition, we decided to stop funding the operations of Accordion and recorded an impairment charge of $0.1 million for the nine months ended September 30, 2004 related to our investment in Accordion. The Board of Directors of Accordion voted to discontinue the operations of Accordion in March 2004.
In February 2003, we made a convertible bridge loan investment in IC4IC totaling $0.05 million. It was determined in March of 2003 that this investment should be impaired, as it was evident that IC4IC would not have or be able to raise sufficient equity or debt to fund its operations. During April 2003, IC4ICs Board of Directors made the decision to discontinue operations.
We will continue to periodically review all of our investments in non-publicly traded companies for impairment in future periods. There can be no assurance that future impairments will not be necessary.
Equity in Net Losses of Affiliates
The decrease in equity losses for the three and nine months ended September 30, 2004 as compared to the same periods in 2003 was due to our adoption of the provisions of FIN 46R in the first quarter of 2004. As a result of the adoption of FIN 46R, we consolidated the results of our investment in OptiX as a cumulative effect of an accounting change in the first quarter of 2004. For the same quarter in the prior year, we had been accounting for our direct and indirect voting interest (which included certain board members and employees) of greater than 20% but less than 50% in our investment in OptiX under the equity method of accounting where our pro rata share of net loss from OptiX was recorded on the consolidated statements of operations and accordingly, the carrying value of the investments was reduced on the consolidated balance sheets.
Change in Fair Value of Derivative Liability
For the three and nine months ended September 30, 2004, we recorded other income of approximately $5.1 million and $12.9 million, respectively to reflect the change in the fair value of derivative liability resulting from issuance of the Plus Cash Notes (for further discussion, please refer to Item 1, Note 7 Convertible Notes of our Unaudited Consolidated Financial Statements). We had no similar income or related loss during the three and nine months ended September 30, 2003.
24
Interest Income (Expense), net
The increase in interest expense, net for the three and nine months ended September 30, 2004, as compared to the same periods in 2003 is primarily due to the amortization of debt discount on the Plus Cash Notes. Also contributing to the increase in interest expense, net is lower interest income due to a lower average cash balance during three and nine months ended September 30, 2004 compared to the three and nine months ended September 30, 2003. At September 30, 2004 and 2003, the effective interest rate on our interest-bearing securities was approximately 1.85% and 1.33%, respectively.
Income Tax Expense
For the nine months ended September 30, 2004 and 2003, income tax expense was $0.2 million and $0.3 million, respectively, reflecting foreign income taxes.
During the three and nine months ended September 30, 2004 and 2003, we evaluated our deferred tax assets as to whether it is more likely than not that the deferred tax assets will be realized. In our evaluation of the realizability of deferred tax assets, we consider projections of future taxable income, the reversal of temporary differences and tax planning strategies. We have evaluated and determined that it is not more likely than not that all of the deferred tax assets will be realized. Accordingly, a valuation reserve was recorded against all of our net deferred tax assets. In future periods, we will not recognize a deferred tax benefit and will maintain a deferred tax valuation allowance until we achieve sustained taxable income. Additionally, in the future, we expect our current income tax expense to be related to taxable income generated by our foreign subsidiaries.
Extraordinary Loss Upon Consolidation of TeraOp (USA), Inc.
In January 2003, FIN 46, Consolidation of Variable Interest Entities (FIN 46) was issued. The interpretation provided guidance on consolidating variable interest entities and applied to all variable interests in variable interest entities created after January 31, 2003. The interpretation required variable interest entities to be consolidated if the equity investment at risk was not sufficient to permit an entity to finance its activities without support from other parties or if the equity investors lack certain specified characteristics. We applied the provisions of FIN 46 to our investment in TeraOp as of February 1, 2003, which required us to consolidate the results of TeraOp.
During the first quarter of 2003, we loaned TeraOp $0.5 million under a new convertible loan agreement, which provided us with additional contractual rights over existing debt or equity investors. In addition, we were also in a position, as a result of the loan, to negotiate a more favorable conversion price of the equity securities of TeraOp and have the ability to control the operations of TeraOp. None of the existing debt or equity investors, other than us, was expected to, absorb any additional losses from their investment given that the equity of TeraOp was negative as of January 31, 2003. As a result, the convertible loan was determined to be a variable interest and TeraOp was considered a variable interest entity, as defined by FIN 46. We calculated the effect of the initial measurement as of January 31, 2003. As a result of this measurement and consolidation of TeraOp, we recognized an extraordinary loss of approximately $0.1 million for the nine months ended September 30, 2003, as the fair value of TeraOps liabilities exceeded its assets by this amount. All significant intercompany balances, including our investments in TeraOp, have been eliminated in consolidation. In September 2004, the Company liquidated its investment in TeraOp and deconsolidated TeraOp from the Companys financial statements. For further discussion, please refer to Item 1, Note 4 Restructuring Liabilities.
Cumulative Effect on Prior Years of Retroactive Application of New Depreciation Method and the Application of FIN 46R
Effective January 1, 2003, we changed the method of depreciating property and equipment to the straight-line method. Depreciation of property and equipment in prior years was computed using the half-year convention method. We evaluated the use and related consumption of all classes of acquired property and equipment. We have determined that many of our assets are used and consumed on a consistent level over their estimated economic lives. Under the half-year convention method, property and equipment placed in service during the first year of acquisition was subject to six months of depreciation expense regardless of when the asset was acquired, placed in service and consumed. We believe that the straight-line method results in a better approximation of the underlying consumption of the asset over its estimated useful life and provides a better matching of revenues and expenses. The effect of the change in depreciation method as of January 1, 2003 was applied retroactively to property and equipment acquisitions of prior years. The cumulative effect of the change with respect to the retroactive application of the straight-line method is approximately an $0.8 million charge and was recorded as such on the consolidated statements of operations for the period ended March 31, 2003. This charge has not been presented net of an income tax benefit as we continue to maintain a full valuation allowance against our net deferred income tax assets. There were no such charges during the three and nine months ended September 30, 2004.
We adopted the provisions of FIN 46R and changed our accounting accordingly in the first quarter of 2004. As a result of the adoption of FIN 46R, we consolidated the results of our investment in OptiX and recorded a charge of approximately $0.3
25
million for the nine months ended September 30, 2004 as a cumulative effect of an accounting change. As disclosed in our Annual Report on Form 10-K for the year ended December 31, 2003, we restated prior period results to reflect the change from the cost to the equity method of accounting for our investment in OptiX because during fiscal 2002, we obtained the ability to significantly influence the operating and financial policies of OptiX through our investments in convertible preferred stock and a bridge loan. This investment restatement reduced the investment balance in OptiX (included in investments in non-publicly traded companies on the consolidated balance sheets), as if accounted for on the equity method, since inception.
In July 2004, we informed OptiX that we planned to discontinue our ongoing funding of OptiXs operations. Consequently, the OptiX Board of Directors voted to wind-down its business and operations. OptiX expects to have the wind-down completed and to permanently close its operations by December 31, 2004. Upon the completion of the wind-down, OptiX will be deconsolidated from our financial statements. For further discussion, please refer to Item 1, Note 4 - Restructuring Liabilities.
26
LIQUIDITY AND CAPITAL RESOURCES
As of September 30, 2004 and December 31, 2003, we had total cash, cash equivalents and investments in marketable securities of approximately $142.9 million and $179.4 million, respectively. This is our primary source of liquidity, as we are not currently generating positive cash flow from our operations. Details of our cash inflows and outflows for the nine months ended September 30, 2004 as well as a summary of our cash, cash equivalents and investments in marketable securities and future commitments are detailed as follows:
Cash, Cash Equivalents and Investments
We have financed our operations and have met our capital requirements since incorporation in 1988 primarily through private and public issuances of equity securities, convertible notes, bank borrowings and cash generated from operations. Our principal sources of liquidity as of September 30, 2004 consisted of $83.3 million in cash and cash equivalents, $26.3 million in short-term investments and $33.4 million in long-term investments in marketable securities for a total cash, cash equivalents and investment balance of $142.9 million. Cash equivalents are instruments with maturities of less than 90 days, short-term investments have maturities of greater than 90 days but less than one year and long-term investments have maturities of greater than one year. Our cash equivalents and investments consist of U.S. Treasury Bills, corporate debt, taxable municipal securities, money market instruments, overnight repurchase investments and commercial paper.
We believe that our existing cash, cash equivalents and investments will be sufficient to fund operating losses, capital expenditures and provide adequate working capital for at least the next twelve months. However, there can be no assurance that events in the future will not require us to seek additional capital and, if so required, that capital will be available on terms favorable or acceptable to us, if at all.
September 30, 2004 |
December 31, 2003 |
Change |
September 30, 2003 |
December 31, 2002 |
Change |
|||||||||||||||
Cash and Cash equivalents |
$ | 83,254 | $ | 142,950 | $ | (59,696 | ) | $ | 143,215 | $ | 150,548 | $ | (7,333 | ) | ||||||
Short term investments |
26,261 | 9,101 | 17,160 | 30,501 | 33,099 | (2,598 | ) | |||||||||||||
Long term investments |
33,421 | 27,300 | 6,121 | 15,314 | 21,819 | (6,505 | ) | |||||||||||||
Total Cash and investments |
$ | 142,936 | $ | 179,351 | $ | (36,415 | ) | $ | 189,030 | $ | 205,466 | $ | (16,436 | ) | ||||||
Cash Inflows and Outflows
During the nine months ended September 30, 2004, the net decrease in cash and cash equivalents was $59.7 million compared to a net decrease of $7.3 million during the nine months ended September 30, 2003. As reported on our consolidated statements of cash flows, our decrease in cash and cash equivalents during the nine months ended September 30, 2004 and 2003 is summarized as follows:
Nine Months Ended September 30, |
||||||||
Tabular dollars in thousands | 2004 |
2003 |
||||||
Net cash used in operating activities |
$ | (31,765 | ) | $ | (34,484 | ) | ||
Net cash (used in) provided by investing activities |
(27,912 | ) | 6,949 | |||||
Net cash provided by financing activities |
250 | 19,892 | ||||||
Effect of foreign exchange rate changes |
(269 | ) | 310 | |||||
Total decrease in cash and cash equivalents |
$ | (59,696 | ) | $ | (7,333 | ) | ||
27
Details of our cash inflows and outflows are as follows during the nine months ended September 30, 2004:
Operating Activities: During the nine months ended September 30, 2004, we used $31.8million in cash and cash equivalents in operating activities as compared with $34.5 million used during the same prior year period. This was comprised primarily of our net loss of $30.7 million and an increase in working capital of $3.2 million partially offset by non-cash charges totaling $2.1 million. The components of our net loss are detailed in our Results of Operations section included above in this Item. Components of our significant non-cash adjustments are as follows:
Non-cash Adjustments |
Nine Months Ended September 30, 2004 (amounts in thousands) |
Explanation of Non-cash Activity | ||||
Depreciation and amortization |
$ | 12,839 | Consists of depreciation of property and equipment as well as amortization of deferred financing fees, patents and unearned compensation. | |||
Change in fair value of derivative liability |
(12,852 | ) | During the nine months ended September 30, 2004, we recorded other income to reflect the change in the fair value of our derivative liability. | |||
Loss on extinguishment of debt |
1,241 | During the nine months ended September 30, 2004, the Company issued an aggregate of 3,278,940 shares of the Companys common stock plus approximately $0.06 million cash in lieu of accrued and unpaid interest in exchange for $5.5 million in aggregate original principal amount of the Plus Cash Notes. | ||||
Other non-cash items, net |
873 | Other non-cash items include items such as our non-cash charge for cumulative effect on prior years of adoption of FIN 46R, adjustments to our restructuring liability, impairment of investments, allowance for doubtful accounts and provision for excess and obsolete inventory. | ||||
Total non-cash adjustments to net loss |
$ | 2,101 | ||||
Investing Activities: Cash used in investing activities was $27.9 million for the nine months ended September 30, 2004 as compared with approximately $6.9 million generated from investing activities for the nine months ended September 30, 2003. Specific investing activity during the nine months ended September 30, 2004 and 2003 was as follows:
| During the nine months ended September 30, 2004, we invested approximately $3.4 million in capital equipment. This compares to $1.3 million in the same period of 2003. |
| We invested approximately $1.4 million in non-publicly traded companies during the nine months ended September 30, 2004 compared to $1.4 million in the same period of 2003. |
| During the nine months ended September 30, 2004, we received cash upon the consolidation of variable interest entities of $0.1 million. |
| Our net investment in held-to-maturity short- and long-term investments during the nine months ended September 30, 2004, was $23.3 million as compared to net proceeds of $9.1 million in the same period of 2003. |
Financing Activities: During the nine months ended September 30, 2004, cash flows from financing activities provided $0.3 million, which consisted primarily of proceeds from the issuance of common stock under our employee stock plans. This compares to $19.9 million generated in the same prior year period, which consisted of proceeds from the issuance of common stock in our employee stock purchase plan of $0.3 million and proceeds from the issuance of 5.45% Convertible Plus Cash NotesSM due 2007 (Plus Cash Notes) of $19.6 million.
Effect of Exchange Rates and Inflation: Exchange rates and inflation have not had a significant impact on our operations or cash flows.
28
Commitments and Significant Contractual Obligations
We have existing commitments to make future interest payments on our existing 4.50% Notes and also to redeem these notes in September 2005. We also have commitments to make future interest payments on our Plus Cash Notes and to redeem these notes in September 2007. Over the remaining life of both the outstanding 4.50% Notes and Plus Cash Notes, we expect to accrue and pay approximately $16.1 million in interest to the holders thereof.
We have outstanding operating lease commitments of approximately $42.0 million, payable over the next fifteen years. Some of these commitments are for space that is not being utilized and, for which, we recorded restructuring charges in prior periods. We are in the process of trying to sublease additional excess space but it is unlikely that any sublease income generated will offset the entire future commitment. As of September 30, 2004, we have sublease agreements totaling $10.4 million to rent portions of our excess facilities over the next six years. We currently believe that we can fund these lease commitments in the future; however, there can be no assurances that we will not be required to seek additional capital or provide additional guarantees or collateral on these obligations.
We have also pledged approximately $0.9 million in available cash and cash equivalents as collateral for stand-by letters of credit that guarantee certain long-term property lease obligations.
There have been no material changes to our contractual obligations reported in our Annual Report on Form 10-K for the year ended December 31, 2003 as filed with the Securities and Exchange Commission on March 3, 2004 since December 31, 2003.
Related Party Transactions
On a limited basis, we conduct certain related party transactions with the companies in which we have equity or debt investments. During May 2003, we entered into an agreement with OptiX for them to provide subcontracting services to us. As a result of this agreement, we paid OptiX approximately $0.4 million and $1.5 million for these subcontracting services for the three and nine months ended September 30, 2004, respectively. During the three and nine months ended September 30, 2003, we paid $0.4 million to OptiX under our subcontracting agreement. We eliminated the effect of these transactions on our unaudited consolidated financial statements as required under FIN 46R and the equity method of accounting for the three and nine months ended September 30, 2004 and 2003, respectively.
As of December 31, 2003, we had cumulatively funded $5.0 million to OptiX, relating to our convertible bridge loan with OptiX, including $1.0 million in cash provided to OptiX during 2003 to fund their net losses. We had no additional funding obligations under our bridge loan agreement with OptiX and have not provided any additional funding to OptiX during the nine months ened September 30, 2004.
In July 2004, we informed OptiX that we planned to discontinue our ongoing funding of OptiXs operations. Consequently, the OptiX Board of Directors voted to wind-down its business and operations. OptiX expects to have the wind-down completed and to permanently close its operations by December 31, 2004. Upon the completion of the wind-down, OptiX will be deconsolidated from our financial statements. For further discussion, please refer to Item 1, Note 4 - Restructuring Liabilities.
Recent Accounting Pronouncement
In January 2003, the FASB issued Interpretation No. 46, Consolidation of Variable Interest Entities, an interpretation of ARB 51 (FIN 46). The interpretation provided guidance on consolidating variable interest entities and applied immediately to variable interests created after January 31, 2003. The guidelines of the interpretation as revised by FIN 46 (revised December 2003), Consolidation of Variable Interest Entities (FIN 46R) became applicable to us in the first quarter of 2004 for variable interest entities created before February 1, 2003. The interpretation required variable interest entities to be consolidated if the equity investment at risk is not sufficient to permit an entity to finance its activities without support from other parties, or the equity investors lack certain specified characteristics.
29
FACTORS THAT MAY AFFECT FUTURE RESULTS
From time to time, information provided by us, statements made by our employees or information included in our filings with the Securities and Exchange Commission (including this Quarterly Report on Form 10-Q) may contain statements that are not historical facts, so-called forward-looking statements, which involve risks and uncertainties. Such forward-looking statements are made pursuant to the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended. In some cases you can identify forward-looking statements by terminology such as may, should, could, will, expect, intend, plans, predict, anticipate, estimate, continue, believe or the negative of these terms or other similar words. These statements discuss future expectations, contain projections of results of operations or of financial condition or state other forward-looking information. When considering forward-looking statements, you should keep in mind the risk factors and other cautionary statements in this Quarterly Report on Form 10-Q.
Our actual future results may differ significantly from those stated in any forward-looking statements. Factors that may cause such differences include, but are not limited to, the factors discussed below. Each of these factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission.
Our operating results may fluctuate because of a number of factors, many of which are beyond our control. If our operating results are below the expectations of public market analysts or investors, then the market price of our common stock could decline. Some of the factors that affect our quarterly and annual results, but which are difficult to control or predict, are:
Our net revenues, may continue to fluctuate.
Our net revenues for the years ended December 31, 2003 and 2002 and 2001 were $23.8 million, $16.6 million and $58.7 million, respectively. Our net revenues recorded during the three and nine months ended September 30, 2004 were $8.3 million and $25.2 million, respectively. Due to current economic conditions it is difficult for us to predict the purchasing activities of our customers and we expect that our net revenues will continue to fluctuate in the future.
We have incurred significant net losses.
Our net losses have been considerable for the fiscal years ended December 31, 2003, 2002 and 2001. Our net losses recorded during the three and nine months ended September 30, 2004 were $8.3 million and $30.7 million, respectively. Due to current economic conditions, we expect that our operating results will continue to fluctuate in the future.
We are using our available cash and investments each quarter to fund our operating activities.
During the nine months ended September 30, 2004, we used $59.4 million of our available cash and cash equivalents, excluding the effect of exchange rate changes, to fund our operating, investing and financing activities and purchased $23.3 million of short- and long-term investments for a total cash and investment usage of $36.1 million.
During the year ended December 31, 2003, we used $7.6 million of our available cash and cash equivalents, excluding the effect of exchange rate changes, to fund our operating, investing and financing activities and redeemed $18.5 million of short- and long-term investments for a total cash and investment usage of $26.1 million. Total cash and investment usage for the year ended December 31, 2003 reflects the net proceeds of approximately $19.5 million from the sale of our 5.45% Convertible Plus Cash NotesSM due 2007 (Plus Cash Notes). Excluding the Plus Cash Notes proceeds, net cash and investment usage for the year ended December 31, 2003 was $45.6 million.
We anticipate that we will use approximately $9.0 million to $11.0 million in cash, cash equivalents and investments during the fourth quarter of 2004 to fund our operations, investments and financing activities. We believe that we will continue to use our available cash, cash equivalents and investments in the future and we believe that we have sufficient cash for our needs for at least the next twelve months. We will continue to experience losses and use our cash, cash equivalents and investments if we do not receive sufficient product orders and our costs are not reduced to offset the decline in revenue.
We continue to have substantial indebtedness after the completion of our exchange offer for some of our convertible notes.
On September 30, 2003, we exchanged $89.7 million of our 4.50% Notes due 2005 (4.50% Notes) for $74.0 million of our Plus Cash Notes. We also issued an additional $24.0 million of our Plus Cash Notes for cash. As of September 30, 2004, we have approximately $116.5 million in principal amount of indebtedness outstanding in the form of our 4.50% Notes and Plus Cash Notes.
In addition to this indebtedness, we may incur substantial additional indebtedness in the future. The level of our indebtedness, among other things, could:
| make it difficult for us to make payments on our 4.50% Notes or our Plus Cash Notes; |
30
| make it difficult for us to obtain any necessary future financing for working capital, capital expenditures, debt service requirements or other purposes; |
| limit our flexibility in planning for, or reacting to changes in, our business; and |
| make us more vulnerable in the event of a downturn in our business. |
There can be no assurance that we will be able to meet our debt service obligations, including our obligations under the 4.50% Notes or the Plus Cash Notes. The terms of our Plus Cash Notes permit the holders thereof to voluntarily convert their notes at any time into a certain number of shares of our common stock and receive a certain amount in cash, which we refer to as the plus cash amount, and, if certain conditions are met, we have the option of settling this plus cash amount in additional shares of our common stock. These Plus Cash Notes also permit us to automatically convert some or all of the Plus Cash Notes into shares of our common stock subject to certain conditions. In addition, we may from time to time seek to exchange these Plus Cash Notes for shares of our common stock or other securities pursuant to exemption from registration afforded by Section 3(a)(9) of the Securities Act of 1933, as amended. As a result of shares of our common stock or other securities being issued upon such conversion or pursuant to such exchanges, our stockholders may experience substantial dilution of their ownership interest. In addition, we may not elect to settle the plus cash amount payable upon voluntary or automatic conversion in additional shares of our common stock, or we may be restricted from doing so pursuant to the terms of the Plus Cash Notes. If a significant percentage of our Plus Cash Notes are voluntarily or automatically converted, we may be required to use all or a significant portion of our available cash, which could have a material adverse effect on our business, prospects, financial condition and operating results.
We may not be able to pay our debt and other obligations.
If our cash, cash equivalents, short- and long-term investments and operating cash flows are inadequate to meet our obligations, we could face substantial liquidity problems. If we are unable to generate sufficient cash flow or otherwise obtain funds necessary to make required payments on the 4.50% Notes, the Plus Cash Notes or our other obligations, we would be in default under the terms thereof, which would permit the holders of the 4.50% Notes, the Plus Cash Notes and our other obligations to accelerate their maturities and which could also cause defaults under any future indebtedness we may incur. Any such default or cross default would have a material adverse effect on our business, prospects, financial condition and operating results. In addition, we cannot be sure that we would be able to repay amounts due in respect of the 4.50% Notes and the Plus Cash Notes if payment of those notes were to be accelerated following the occurrence of an event of default as defined in the respective indentures of the 4.50% Notes and Plus Cash Notes.
We may incur additional indebtedness, including secured indebtedness, which may have rights to payment superior to our 4.50% Notes and Plus Cash Notes.
Our 4.50% Notes and Plus Cash Notes are unsecured obligations. The terms of the 4.50% Notes and the Plus Cash Notes do not limit the amount of additional indebtedness, including secured indebtedness, that we can create, incur, assume or guarantee. Upon any distribution of our assets upon any insolvency, dissolution or reorganization, the payment of the principal of and interest on any secured indebtedness will be distributed out of our assets, which represent the security for such indebtedness. There may not be sufficient assets remaining to pay amounts due on any or all of the 4.50% Notes or the Plus Cash Notes then outstanding once payment of the principal and interest on our secured indebtedness has been made.
If we seek to secure additional financing we may not be able to do so. If we are able to secure additional financing our stockholders may experience dilution of their ownership interest or we may be subject to limitations on our operations.
We believe that our existing cash, cash equivalents and short- and long-term investments will be sufficient to fund operating losses and capital expenditures and provide adequate working capital for at least the next twelve months. However, there can be no assurance that events in the future will not require us to seek additional capital and, if so required, that capital will be available on terms favorable or acceptable to us, if at all.
If we are unable to generate sufficient cash flows from operations to meet our anticipated needs for working capital and capital expenditures, we may need to raise additional funds. If we raise additional funds through the issuance of equity securities, our stockholders may experience dilution of their ownership interest, and the newly issued securities may have rights superior to those of common stock. If we raise additional funds by issuing debt, we may be subject to limitations on our operations.
The terms of the Plus Cash Notes include voluntary and automatic conversion provisions upon which shares of our common stock would be issued, and would also permit us to satisfy certain interest and other payments with additional shares of our common stock. As a result of these shares of our common stock being issued, our stockholders may experience substantial dilution of their ownership interest.
31
On April 6, 2004, the Company filed a shelf registration statement on Form S-3 (Registration No. 333-114238) with the Securities and Exchange Commission (SEC) providing for the offer, from time to time, of common stock, preferred stock, debt securities and warrants up to an aggregate of $60.0 million. On April 19, 2004, the SEC declared effective the shelf registration statement. This enables us to, at any time in the subsequent two-year period, make an offering of any individual security covered by the shelf registration statement as well as any combination thereof, subject to market conditions and our capital needs. Such market conditions may not allow for terms favorable to us. Any such offering which results in the issuance of shares of our common stock may cause our stockholders to experience substantial dilution of their ownership interest. We may use the net proceeds from the sale of these securities for general corporate purposes, which may include repayment or refinancing of existing indebtedness, acquisitions, investments, capital expenditures, repurchase of its capital stock and for any other purposes that we may specify in any prospectus supplement.
If the trading price of our common stock fails to comply with the continued listing requirements of The Nasdaq National Market, we would face possible delisting, which would result in a limited public market for our common stock and make obtaining future debt or equity financing more difficult for us.
Our common stock is listed on The Nasdaq National Market and is subject to certain listing requirements, including the requirement that the closing bid price for our shares of common stock exceed $1.00. On October 25, 2004, the closing bid price for our shares was $1.04. If we do not continue to comply with the Nasdaq listing requirements, Nasdaq may provide written notification to us regarding the delisting of our securities. At that time, we would have the right to request a hearing to appeal the Nasdaq determination and would also have the option to apply to transfer our securities to The Nasdaq SmallCap Market.
We cannot be sure that our price will comply with the requirements for continued listing of our common stock on The Nasdaq National Market, or that any appeal of a decision to delist our common stock will be successful. If our common stock loses its status on The Nasdaq National Market and we are not successful in obtaining a listing on The Nasdaq SmallCap Market, shares of our common stock would likely trade in the over-the-counter market bulletin board, commonly referred to as the pink sheets.
If our stock were to trade on the over-the-counter market, selling our common stock could be more difficult because smaller quantities of shares would likely be bought and sold, transactions could be delayed, and security analysts coverage of us may be reduced. In addition, in the event our common stock is delisted, broker-dealers have certain regulatory burdens imposed upon them, which may discourage broker-dealers from effecting transactions in our common stock, further limiting the liquidity thereof. These factors could result in lower prices and larger spreads in the bid and ask prices for shares of common stock.
Such delisting from The Nasdaq National Market or future declines in our stock price could also greatly impair our ability to raise additional necessary capital through equity or debt financing, and could significantly increase the ownership dilution to stockholders caused by our issuing equity in financing or other transactions.
We expect that our operating results may fluctuate in the future due to variable demand in our markets.
Our business is characterized by short-term orders and shipment schedules, and customer orders typically can be cancelled or rescheduled without significant penalty to our customers. Because we do not have substantial non-cancelable backlog, we typically plan our production and inventory levels based on internal forecasts of customer demand, which are highly unpredictable and can fluctuate substantially. Future fluctuations in our operating results may also be caused by a number of factors, many of which are beyond our control.
In response to anticipated long lead times to obtain inventory and materials from our foundries, we may order inventory and materials in advance of anticipated customer demand, which might result in excess inventory levels if the expected orders fail to materialize. As a result, we cannot predict the timing and amount of shipments to our customers, and any significant downturn in customer demand for our products would reduce our quarterly and our annual operating results. As a result of these conditions, during the nine months ended September 30, 2004 and 2003 we recorded write-downs for excess inventories totaling $0.6 million and $1.5 million, respectively. In addition, during fiscal years ended 2003, 2002 and 2001, we recorded write-downs for excess inventories totaling $1.5 million, $4.8 million and $39.2 million, respectively.
32
Our success depends on the timely development of new products, and we face risks of product development delays.
Our success depends upon our ability to develop new VLSI devices and software for existing and new markets. The development of these new devices and software is highly complex, and from time to time we have experienced delays in completing the development of new products. Successful product development and introduction depends on a number of factors, including the following:
| accurate new product definition; |
| timely completion and introduction of new product designs; |
| availability of foundry capacity; |
| achievement of manufacturing yields; and |
| market acceptance of our products and our customers products. |
Our success also depends upon our ability to do the following:
| build products to applicable standards; |
| develop products that meet customer requirements; |
| adjust to changing market conditions as quickly and cost-effectively as necessary to compete successfully; |
| introduce new products that achieve market acceptance; and |
| develop reliable software to meet our customers application needs in a timely fashion. |
In addition, we cannot ensure that the systems manufactured by our customers will be introduced in a timely manner or that such systems will achieve market acceptance.
We may have to further restructure our business.
During the third quarter of 2004, the Company recorded restructuring charges totaling $0.5 million resulting from the Companys liquidation of its investment in TeraOp and the wind-down of the business and operations of OptiX, two Israeli development stage companies consolidated in the Companys financial statements under FIN 46R. In addition, during the third quarter of 2004, the Company began the process of exploring alternatives to disengage from its research and development subsidiary in Belgium, although the Company has not committed to any plans at this time. In January 2003, we announced a restructuring plan in order to lower our operating expense run-rate due to then current and anticipated business conditions. This plan resulted in a workforce reduction of approximately 24% of existing personnel. Also, we announced the closing of our South Brunswick, New Jersey (SOSi) design center, and reduced staff in Bedford, Massachusetts and Shelton, Connecticut. This workforce reduction also impacted our Switzerland and Belgium locations. In addition, we postponed the completion of the IAD product line and archived the related intellectual property until that market returns, if ever.
During 2002, we announced a restructuring plan due to continued weakness in our business and the industry. As a result of this plan, we eliminated 56 positions and announced the closing of design centers in Milpitas, California and Raleigh, North Carolina. In conjunction with this restructuring, we discontinued certain product lines and strategically refocused our research and development efforts. As a result of these plans, we incurred restructuring charges and asset impairments of approximately $5.5 million.
During 2001, we announced restructuring plans as a result of then current and anticipated business conditions. As a result of those plans, we incurred restructuring charges and asset impairments of approximately $34.2 million related to workforce reductions of 77 positions throughout our Company and the related consolidation of several of our leased facilities.
We may have to make further restructuring charges if our operating expense run-rate does not continue to decline in the face of current and anticipated business conditions.
We anticipate that shipments of our products to relatively few customers will continue to account for a significant portion of our total net revenues.
Historically, a relatively small number of customers have accounted for a significant portion of our total net revenues in any particular period. For the three months ended September 30, 2004 and 2003, shipments to our top five customers, including sales to distributors, accounted for approximately 50% and 53% of our total net revenues, respectively. For the years ended December 31, 2003 and 2002, shipments to our top five customers, including sales to distributors, accounted for approximately 64% and 70% of our total net revenues, respectively. We expect that a limited number of customers may account for a substantial portion of our total net revenues for the foreseeable future.
33
Some of the following may reduce our total net revenues or adversely affect our business:
| reduction, delay or cancellation of orders from one or more of our significant customers; |
| development by one or more of our significant customers of other sources of supply for current or future products; |
| loss of one or more of our current customers or a disruption in our sales and distribution channels; and |
| failure of one or more of our significant customers to make timely payment of our invoices. |
We cannot be certain that our current customers will continue to place orders with us, that orders by existing customers will return to the levels of previous periods or that we will be able to obtain orders from new customers. We have no long-term volume purchase commitments from any of our significant customers. The following tables set forth the percentage of net revenues attributable to our major distributors as well as the significant customers that had total purchases (either direct or through distributors) of greater than 10% of net revenues for the nine months ended September 30, 2004 as well as the years ended December 31, 2003, 2002 and 2001:
Nine Months Ended September 30, 2004 |
Years Ended December 31, |
||||||||||
2003 |
2002 |
2001 |
|||||||||
Distributors: |
|||||||||||
Arrow Electronics, Inc.(1) |
13% | 11 | % | 19 | % | * | |||||
Insight Electronics, Inc.(2) |
12% | 12 | % | 10 | % | 24 | % | ||||
Weone Corporation |
* | * | 13 | % | 10 | % | |||||
Unique Memec(3) |
* | * | * | 10 | % | ||||||
Significant Customers: |
|||||||||||
Siemens AG(3) |
24% | 28 | % | 19 | % | 21 | % | ||||
Tellabs, Inc.(1) |
12% | 12 | % | 23 | % | * | |||||
Cisco Systems, Inc.(2) |
* | * | 11 | % | * | ||||||
Redback Networks, Inc. |
* | * | * | 12 | % | ||||||
Samsung Corporation |
* | * | * | 11 | % | ||||||
Lucent Technologies, Inc. |
* | * | * | 11 | % |
(1) | The primary end customer of the shipments to Arrow Electronics, Inc. is Tellabs, Inc. |
(2) | The end customers of the shipments to Insight Electronics, Inc. include: Spirent Communications, Cisco Systems and Sonus Network, Inc. for the nine months ended September 30, 2004. |
(3) | A portion of the shipments to Siemens AG was distributed through Unique Memec. |
* | Revenues were less than 10% of our net revenues in these periods. |
The cyclical nature of the communication semiconductor industry affects our business and we have experienced a significant downturn since 2000.
We provide semiconductor devices to the telecommunications and data communications markets. The semiconductor industry is highly cyclical. After several years of rapid growth our markets experienced a downturn beginning in 2001. Downturns are characterized by:
| diminished product demand; |
| accelerated erosion of average selling prices; |
| production over-capacity; and |
Our markets stabilized in 2003 and we believe that we are now in the early stages of a market recovery. However, demand remains well below the levels prior to the downturn. We may experience substantial fluctuations in future operating results due to general semiconductor industry conditions, overall economic conditions, seasonality of customers buying patterns and other factors.
Our international business operations expose us to a variety of business risks.
Foreign markets are a significant part of our net revenues. Foreign shipments accounted for 60% and 61% of our total net revenues for the three and nine months ended September 30, 2004, respectively and 72% for the year ended December 31, 2003. We expect foreign markets to continue to account for a significant percentage of our total net revenues. A significant portion of our total net revenues will, therefore, be subject to risks associated with foreign markets, including the following:
| unexpected changes in legal and regulatory requirements and policy changes affecting the telecommunications and data communications markets; |
34
| changes in tariffs; |
| exchange rates, currency controls and other barriers; |
| political and economic instability; |
| difficulties in accounts receivable collection; |
| difficulties in managing distributors and representatives; |
| difficulties in staffing and managing foreign operations; |
| difficulties in protecting our intellectual property overseas; |
| seasonality of customer buying patterns; and |
| potentially adverse tax consequences. |
Although substantially all of our total net revenues to date have been denominated in U.S. dollars, the decline in value of the U.S. dollar in relation to foreign currencies may also reduce our total net revenues from foreign customers. To the extent that we expand our international operations or change our pricing practices to denominate prices in foreign currencies, we will expose our margins to increased risks of currency fluctuations. We have assessed the risks related to foreign exchange fluctuations, and have determined at this time that any such risk is not material.
Our net product revenues depend on the success of our customers products.
Our customers generally incorporate our new products into their products or systems at the design stage. However, customer decisions to use our products (design wins), which can often require significant expenditures by us without any assurance of success, often precede the generation of production revenues, if any, by a year or more. In addition, even after we achieve a design win, a customer may require further design changes. Implementing these design changes can require significant expenditures of time and expense by us in the development and pre-production process. Moreover, the value of any design win will largely depend upon the commercial success of the customers product and on the extent to which the design of the customers systems accommodates components manufactured by our competitors. We cannot ensure that we will continue to achieve design wins in customer products that achieve market acceptance.
We must successfully transition to new process technologies to remain competitive.
Our future success depends upon our ability to do the following:
| to develop products that utilize new process technologies; |
| to introduce new process technologies into the marketplace ahead of competitors; and |
| to have new process technologies selected to be designed into products of leading systems manufacturers. |
Semiconductor design and process methodologies are subject to rapid technological change and require large expenditures for research and development. We currently manufacture our products using 0.8, 0.5, 0.35, 0.25, 0.18 and 0.13 micron complementary metal oxide semiconductor (CMOS) processes and a 1.0 micron bipolar CMOS (BiCMOS) process. We continuously evaluate the benefits, on a product-by-product basis, of migrating to smaller geometry process technologies. Other companies in the industry have experienced difficulty in transitioning to new manufacturing processes and, consequently, have suffered increased costs, reduced yields or delays in product deliveries. We believe that transitioning our products to smaller geometry process technologies will be important for us to remain competitive. We cannot be certain that we can make such a transition successfully, if at all, without delay or inefficiencies.
We sell a range of products with varying gross profits. Our total gross profits will be adversely affected if most of our shipments are of products with low gross profits.
We currently sell more than 50 products. Some of our products have a high gross profit while others do not. If our customers decide to buy more of our products with low gross profits and fewer of our products with high gross profits, our total gross profits could be adversely affected. We plan our mix of products based on our internal forecasts of customer demand, which are highly unpredictable and can fluctuate substantially.
The price of our products tends to decrease over the lives of our products.
Historically, average selling prices for a product in the communication semiconductor industry have decreased over the life of a product, and, as a result, we believe that the average selling prices of our existing products may decrease in the future. Decreases in the price of our existing products would adversely affect our operating results.
35
Our success depends on the rate of growth of the global communications infrastructure.
We derive virtually all of our total net revenues from products for telecommunications and data communications applications.
These markets are characterized by the following:
| susceptibility to seasonality of customer buying patterns; |
| subject to general business cycles; |
| intense competition; |
| rapid technological change; and |
| short product life cycles. |
In addition, although the telecommunications and data communications equipment markets grew rapidly in the late 1990s and 2000, we have experienced a significant decline in these markets since 2000. We anticipate that these markets will continue to experience significant volatility in the near future.
Our products must successfully include industry standards to remain competitive.
Products for telecommunications and data communications applications are based on industry standards, which are continually evolving. Our future success will depend, in part, upon our ability to successfully develop and introduce new products based on emerging industry standards, which could render our existing products unmarketable or obsolete. If the telecommunications or data communications markets evolve to a new set of standards, we cannot be certain that we will be able to design and manufacture new products successfully that address the needs of our customers and include the new standards or that such new products will meet with substantial market acceptance.
Our intellectual property indemnification practices may adversely impact our business.
We have historically agreed to indemnify our customers for certain costs and damages of intellectual property rights in circumstances where our product is the factor creating the customers infringement exposure. This practice may subject us to significant indemnification claims by our customers. In some instances, our products are designed for use in devices manufactured by our customers that comply with international standards. These international standards are often covered by patent rights held by third parties, which may include our competitors. The costs of obtaining licenses from holders of patent rights essential to such international standards could be high. The cost of not obtaining such licenses could also be high if a holder of such patent rights brings a claim for patent infringement. We are not aware of any claimed violations on our part. However, we cannot assure you that claims for indemnification will not be made or that if made, such claims would not have a material adverse effect on our business, results of operations or financial condition.
We continue to expense our new product process development costs when incurred.
In the past, we have incurred significant new product and process development costs because our policy is to expense these costs, including tooling, fabrication and pre-production expenses, at the time that they are incurred. We may continue to incur these types of expenses in the future. These additional expenses will have a material and adverse effect on our operating results in future periods.
We face intense competition in the communication semiconductor market.
The communication semiconductor industry is intensely competitive and is characterized by the following:
| rapid technological change; |
| subject to general business cycles; |
| limited access to fabrication capacity; |
| price erosion; |
| unforeseen manufacturing yield problems; and |
| heightened international competition in many markets. |
These factors are likely to result in pricing pressures on our products, thus potentially affecting our operating results.
Our ability to compete successfully in the rapidly evolving area of high-performance integrated circuit technology depends on factors both within and outside our control, including:
| success in designing and subcontracting the manufacture of new products that implement new technologies; |
36
| protection of our products by effective use of intellectual property laws; |
| product quality; |
| reliability; |
| price; |
| efficiency of production; |
| failure to find alternative manufacturing sources to produce VLSI devices with acceptable manufacturing yields; |
| the pace at which customers incorporate our products into their products; |
| success of competitors products; and |
| general economic conditions. |
The telecommunications and data communications industries, which are our primary target markets, have become intensely competitive because of deregulation, heightened international competition and a significant decrease in demand since 2000.
We rely on outside fabrication facilities, and our business could be hurt if our relationships with our foundry suppliers are damaged.
We do not own or operate a VLSI circuit fabrication facility. Five foundries currently supply us with most of our semiconductor device requirements. Four of these relationships are governed by foundry agreements. While we have had good relations with these foundries, we cannot be certain that we will be able to renew or maintain contracts with them or negotiate new contracts to replace those that expire. In addition, we cannot be certain that renewed or new contracts will contain terms as favorable as our current terms. There are other significant risks associated with our reliance on outside foundries, including the following:
| the lack of assured semiconductor wafer supply and control over delivery schedules; |
| the unavailability of, or delays in obtaining access to, key process technologies; and |
| limited control over quality assurance, manufacturing yields and production costs. |
Reliance on third-party fabrication facilities limits our ability to control the manufacturing process.
Manufacturing integrated circuits is a highly complex and technology-intensive process. Although we try to diversify our sources of semiconductor device supply and work closely with our foundries to minimize the likelihood of reduced manufacturing yields, our foundries occasionally experience lower than anticipated manufacturing yields, particularly in connection with the introduction of new products and the installation and start-up of new process technologies. Such reduced manufacturing yields have at times, reduced our operating results. A manufacturing disruption at one or more of our outside foundries, including, without limitation, those that may result from natural disasters, accidents, acts of terrorism or political instability or other natural occurrences, could impact production for an extended period of time.
Our dependence on a small number of fabrication facilities exposes us to risks of interruptions in deliveries of semiconductor devices.
We purchase semiconductor devices from outside foundries pursuant to purchase orders, and we do not have a guaranteed level of production capacity at any of our foundries. We provide the foundries with forecasts of our production requirements. However, the ability of each foundry to provide wafers to us is limited by the foundrys available capacity and the availability of raw materials. Therefore, our foundry suppliers could choose to prioritize capacity and raw materials for other customers or reduce or eliminate deliveries to us on short notice. Accordingly, we cannot be certain that our foundries will allocate sufficient capacity to satisfy our requirements.
We have been, and expect in the future to be, particularly dependent upon a limited number of foundries for our VLSI device requirements. In particular, as of the date of this Quarterly Report on Form 10-Q, a single foundry manufactures all of our BiCMOS devices. As a result, we expect that we could experience substantial delays or interruptions in the shipment of our products due to any of the following:
| sudden demand for an increased amount of semiconductor devices or sudden reduction or elimination of any existing source or sources of semiconductor devices; |
37
| time required to qualify alternative manufacturing sources for existing or new products could be substantial; and |
| failure to find alternative manufacturing sources to produce VLSI devices with acceptable manufacturing yields. |
Our failure to protect our proprietary rights, or the costs of protecting these rights, may harm our ability to compete.
Our success depends in part on our ability to obtain patents and licenses and to preserve other intellectual property rights covering our products and development and testing tools. To that end, we have obtained certain domestic and foreign patents and intend to continue to seek patents on our inventions when appropriate. The process of seeking patent protection can be time consuming and expensive. We cannot ensure the following:
| that patents will be issued from currently pending or future applications; |
| that our existing patents or any new patents will be sufficient in scope or strength to provide meaningful protection or any commercial advantage to us; |
| that foreign intellectual property laws will protect our foreign intellectual property rights; and |
| that others will not independently develop similar products, duplicate our products or design around any patents issued to us. |
Intellectual property rights are uncertain and adjudication of such rights involve complex legal and factual questions. We may be unknowingly infringing on the proprietary rights of others and may be liable for that infringement, which could result in significant liability for us. We occasionally receive correspondence from third parties alleging infringement of their intellectual property rights. If we are found to infringe the proprietary rights of others, we could be forced to either seek a license to the intellectual property rights of others or alter our products so that they no longer infringe the proprietary rights of others. A license could be very expensive to obtain or may not be available at all. Similarly, changing our products or processes to avoid infringing the rights of others may be costly or impractical.
We are responsible for any patent litigation costs. If we were to become involved in a dispute regarding intellectual property, whether ours or that of another company, we may have to participate in legal proceedings in the United States Patent and Trademark Office or in United States or foreign courts to determine any or all of the following issues: patent validity, patent infringement, patent ownership or patent inventorship. These types of proceedings may be costly and time consuming for us, even if we eventually prevail. If we do not prevail, we may be forced to pay significant damages, obtain a license, if available, or stop making a certain product. From time to time we may undertake to prosecute patent litigation against others and as part of such litigation, other parties may allege that our patents are not infringed, are invalid and are unenforceable.
We also rely on trade secrets, proprietary know-how and confidentiality provisions in agreements with employees and consultants to protect our intellectual property. Such parties may not comply with the terms of their agreements with us, and we may not be able to adequately enforce our rights against these parties.
Our stock price is volatile.
The market for securities for communication semiconductor companies, including our Company, has been highly volatile. The market sale price of our common stock has fluctuated between a low of $0.21 and a high of $74.69 during the period from June 19, 1995 to September 30, 2004. The closing price was $1.04 on October 25, 2004. It is likely that the price of our common stock will continue to fluctuate widely in the future. Factors affecting the trading price of our common stock include:
| market responses to quarter-to-quarter variations in operating results; |
| announcements of technological innovations or new products by us or our competitors; |
| current market conditions in the telecommunications and data communications equipment markets (we have experienced a significant downturn since 2000); and |
| changes in earnings estimates by analysts. |
We could be subject to class action litigation due to stock price volatility, which if it occurs, will distract our management and could result in substantial costs or large judgments against us.
In the past, securities and class action litigation has often been brought against companies following periods of volatility in the market prices of their securities. We may be the target of similar litigation in the future. Securities litigation could result in substantial costs and divert our managements attention and resources, which could cause serious harm to our business, operating results and financial condition or dilution to our stockholders.
38
We may engage in acquisitions that may harm our operating results, dilute our stockholders and cause us to incur debt or assume contingent liabilities.
We may pursue acquisitions from time to time that could provide new technologies, skills, products or service offerings. Future acquisitions by us may involve the following:
| use of significant amounts of cash and cash equivalents; |
| potentially dilutive issuances of equity securities; and |
| incurrence of debt or amortization expenses related to intangible assets with definitive lives. |
In addition, acquisitions involve numerous other risks, including:
| diversion of managements attention from other business concerns; |
| risks of entering markets in which we have no or limited prior experience; and |
| unanticipated expenses and operational disruptions while acquiring and integrating new acquisitions. |
From time to time, we have engaged in discussions with third parties concerning potential acquisitions of product lines, technologies and businesses. However, we currently have no commitments or agreements with respect to any such acquisition. If such an acquisition does occur, we cannot be certain that our business, operating results and financial condition will not be materially adversely affected or that we will realize the anticipated benefits of the acquisition.
Our business could be harmed if we fail to integrate future acquisitions adequately.
During the past six years, we have acquired five privately-held companies based in the United States and Europe. The integration of the operations of our five acquisitions, ADV Engineering S.A., acquired in January 2001, Horizon Semiconductors, Inc., acquired in February 2001, Onex Communications Corporation, acquired in September 2001, SOSi acquired in March 2002 , and ASIC Design Services, Inc., acquired in August 2003 have been completed.
Our management must devote time and resources to the integration of the operations of any future acquisitions. The process of integrating research and development initiatives, computer and accounting systems and other aspects of the operations of any future acquisitions presents a significant challenge to our management. This is compounded by the challenge of simultaneously managing a larger and more geographically dispersed entity.
Future acquisitions could present a number of additional difficulties of integration, including:
| difficulties in integrating personnel with disparate business backgrounds and cultures; |
| difficulties in defining and executing a comprehensive product strategy; and |
| difficulties in minimizing the loss of key employees of the acquired company. |
If we delay integrating or fail to integrate operations or experience other unforeseen difficulties, the integration process may require a disproportionate amount of our managements attention and financial and other resources. Our failure to address these difficulties adequately could harm our business or financial results, and we could fail to realize the anticipated benefits of the transaction.
We have in the past, as a result of industry conditions, discontinued or abandoned certain product lines acquired through prior acquisitions.
We have made, and may continue to make, investments in development stage companies, which may not produce any returns for us in the future.
We have made investments in early stage venture-backed, start-up companies that develop technologies that we believe are complementary to our product roadmap. The following table summarizes these investments as of September 30, 2004:
Investee Company |
Initial Investment Date |
Technology | ||
Opulan Technologies |
April 2003 | High performance and cost-effective IP convergence ASSPs (application-specific standard products) | ||
Metanoia Technologies Incorporated |
March 2004 | xDSL Next Generation Chips |
We plan to continue to use our cash to make selected investments in these types of companies. Certain companies in which we invested in the past have failed, and we have lost our entire investment in them. These investments involve all the risks
39
normally associated with investments in development stage companies. As such, there can be no assurance that we will receive a favorable return on these or any future venture-backed investments that we may make. Additionally, our original and any future investments may continue to become impaired if these companies do not succeed in the execution of their business plans. Any further impairment or equity losses in these investments could negatively impact our future operating results. Please refer to Item 1, Note 4 Restructuring Liabilities for further discussion of impairment of our investments in these types of companies.
The loss of key management could affect our ability to run our business.
Our success depends largely upon the continued service of our executive officers, including Dr. Santanu Das, Chairman of the Board of Directors, Chief Executive Officer and President, and other key management and technical personnel and on our ability to continue to attract, retain and motivate other qualified personnel.
Provisions of our certificate of incorporation, by-laws, stockholder rights plan and Delaware law may discourage take-over offers and may limit the price investors would be willing to pay for our common stock.
Delaware corporate law contains, and our certificate of incorporation and by-laws and shareholder rights plan contain, certain provisions that could have the effect of delaying, deferring or preventing a change in control of our Company even if a change of control would be beneficial to our stockholders. These provisions could limit the price that certain investors might be willing to pay in the future for shares of our common stock. Certain of these provisions:
| authorize the issuance of blank check preferred stock (preferred stock which our Board of Directors can create and issue without prior stockholder approval) with rights senior to those of common stock; |
| prohibit stockholder action by written consent; |
| establish advance notice requirements for submitting nominations for election to the Board of Directors and for proposing matters that can be acted upon by stockholders at a meeting; and |
| dilute stockholders who acquire more than 15% of our common stock. |
Acts of terrorism affecting our locations, or those of our suppliers, in the United States or internationally may negatively impact our business.
We operate our businesses in the United States and internationally, including the operation of design centers in India and Europe. We also work with companies in Israel that provide research and design services for us and with companies in Taiwan that fabricate our products. Some of these countries have in the past been subject to terrorist acts and could continue to be subject to acts of terrorism. If our facilities, or those of our suppliers, are affected by a terrorist act, our employees could be injured and our facilities damaged, which could lead to loss of skill sets and affect the development or fabrication of our products, which could lead to lower short- and long-term revenues. In addition, terrorist acts in the areas in which we operate or in which our suppliers operate could lead to changes in security and operations at those locations, which could increase our operating costs. Although we have no reason to believe that our facilities, or those of our suppliers, may be the subject of a terrorist attack, we cannot be sure that this will not happen.
We may have difficulty obtaining director and officer liability insurance in acceptable amounts for acceptable rates.
Like most other public companies, we carry insurance protecting our directors and officers against claims relating to the conduct of our business. This insurance covers, among other things, the costs incurred by companies and their board of directors and officers to defend against and resolve claims relating to such matters as securities class action claims. These claims typically are extremely expensive to defend against and resolve. We pay significant premiums to acquire and maintain this insurance, which is provided by third-party insurers, and we agree to underwrite a portion of such exposures under the terms of the insurance coverage. Each year we negotiate with insurers to renew our directors and officers insurance. Over the last several years we have experienced substantial volatility in the premiums that we must pay for this insurance. In the current economic environment, we cannot ensure that in the future we will be able to obtain sufficient directors and officers liability insurance coverage at acceptable rates or with acceptable terms, conditions and retentions.
Failure to obtain such insurance could have a material adverse impact on future financial results in the event that we are required to defend against and resolve any securities claims made against our Company, our board of directors and officers. Further, the inability to obtain such insurance in adequate amounts may impair our future ability to attract or retain qualified directors and/or officers.
40
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Interest Rate Risk. We have investments in money market accounts, government securities and commercial paper that earn interest income that is a function of the market rates. As a result, we have exposure to changes in interest rates. For example, if interest rates were to decrease by one half percentage point from their current levels, our potential interest income for the remainder of 2004, assuming a constant cash balance, would decrease by approximately $0.2 million. We do, however, expect our cash balance to decline during 2004 and expect that our interest income will therefore also decrease proportionately.
Foreign Currency Exchange Risk. As substantially all of our net revenues are currently made or denominated in U.S. dollars, a strengthening of the dollar could make our products less competitive in foreign markets. We incur a portion of our expenses in currencies other than U.S. dollars. For the nine months ended September 30, 2004, operating expenses incurred in foreign currency were approximately 23% of our total operating expenses. Although we have not experienced significant foreign exchange rate losses to date, we may in the future, especially to the extent that we do not engage in hedging. We do not enter into derivative financial instruments for trading or speculative purposes. The economic impact of currency exchange rate movements on our operating results is complex because such changes are often linked to variability in real growth, inflation, interest rates, governmental actions and other factors. These changes, if material, may cause us to adjust our financing and operating strategies. Consequently, isolating the effect of changes in currency does not incorporate these other important economic factors.
Fair Value of Financial Instruments. As of September 30, 2004, our long-term debt consisted of convertible notes with interest at fixed rates of 4.50% and 5.45%, respectively. Consequently, we do not have significant interest rate exposure on the cash flow associated with our convertible notes. However, the fair market value of the convertible notes is subject to significant fluctuation due to changes in market interest rates and their convertibility into shares of our common stock pursuant to their terms. The fair market value of our outstanding 4.50% Notes is approximately $23.3 million and $22.3 million at September 30, 2004 and December 31, 2003, respectively. The fair market value of our outstanding Plus Cash Notes was approximately $75.5 million and $96.3 million at September 30, 2004 and December 31, 2003, respectively. Among other factors, changes in interest rates and the price of our common stock affect the fair value of our convertible notes. For further discussion, please refer to Critical Accounting Policies and Use of Estimates in Item 2 - Managements Discussion and Analysis of Financial Condition and Results of Operations for additional information on and analysis of our derivative liability associated with our Plus Cash Notes.
41
ITEM 4. CONTROLS AND PROCEDURES
As of the end of the period covered by this report, our management, including our President and Chief Executive Officer and Senior Vice President, Chief Financial Officer and Treasurer, carried out an evaluation of the effectiveness of the Companys disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e)) of the Company. Based upon and as of that date of evaluation, these officers have concluded that our disclosure controls and procedures are in effect such that all material information relating to us and our consolidated subsidiaries required to be disclosed in our periodic filings with the Securities and Exchange Commission (i) is recorded, processed, summarized and reported within the required time period, and (ii) is accumulated and communicated to the Companys management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
During the three months ended September 30, 2004, there were no changes in the Companys internal controls over financial reporting identified in connection with this evaluation that have materially affected, or are reasonably likely to materially affect the Companys internal controls over financial reporting.
Limitations Inherent in all Controls.
The Companys management, including the President and Chief Executive Officer, and Senior Vice President, Chief Financial Officer and Treasurer, recognize that our disclosure controls and our internal controls (discussed above) cannot prevent all errors or all attempts at fraud. Any controls system, no matter how well crafted and operated, can only provide reasonable, and not absolute, assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Because of the inherent limitations in any control system, no evaluation or implementation of a control system can provide complete assurance that all control issues and all possible instances of fraud have been or will be detected.
42
We are not party to any material litigation proceedings. However, we are currently prosecuting civil action number 03-10228NG in U.S. District Court in Massachusetts instituted on February 4, 2003, entitled TranSwitch Corp. v. Galazar Networks, Inc., and are responsible for litigation costs therefrom. We initially asserted that Galazar Networks, Inc. (Galazar) infringed three of our United States patents, and Galazar has alleged that those three patents are not infringed, are invalid and are unenforceable, and counter claimed alleging unfair competition. The Company and Galazar are presently litigating whether the Company should be allowed to replace the patent infringement counts with a count for false advertising and unfair competition, and Galazar is seeking to add a counterclaim for antitrust law violation. There can be no assurances that we will be successful in our suit against Galazar or that Galazar will be unsuccessful in its allegations and counterclaims.
From time to time, we may be subject to other legal proceedings and claims in the ordinary course of business. We are not currently aware of any such proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on the business, financial condition or results of operations of the Company.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
On September 30, 2003, we issued $98.0 million in aggregate original principal amount of our Plus Cash Notes. During the nine months ended September 30, 2004, we issued an aggregate of 3,278,940 shares of our common stock plus approximately $0.06 million cash in lieu of accrued and unpaid interest in exchange for $5.5 million in aggregate original principal amount of our Plus Cash Notes. The shares issued were exempt from registration pursuant to Section 3(a)(9) of the Securities Act of 1933, as amended. No commission or other remuneration was paid or given directly or indirectly for soliciting these transactions. The Company did not effect any such exchanges during the three months ended September 30, 2004.
In order to reduce future cash interest payments, as well as future amounts due at maturity, we may, from time to time, enter into similar exchange transactions, or otherwise seek to repurchase our Plus Cash Notes in open market or privately negotiated transactions. We will evaluate any such transactions in light of then existing market conditions. The amounts involved in any such transactions, individually or in the aggregate, may be material.
43
Exhibit 31.1 | CEO Certification pursuant to Rule 13a-14(a) and Rule 15-d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (filed herewith) | |
Exhibit 31.2 | CFO Certification pursuant to Rule 13a-14(a) and Rule 15-d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (filed herewith) | |
Exhibit 32.1 | CEO and CFO Certification pursuant to Rule 13a-14(b) and Rule 15-d-14(b) of the Securities Exchange Act of 1934, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (filed herewith) |
44
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
TRANSWITCH CORPORATION | ||
October 29, 2004 |
/s/ Dr. Santanu Das | |
Date | Dr. Santanu Das Chairman of the Board, Chief Executive Officer and President (Chief Executive Officer) | |
October 29, 2004 |
/s/ Peter J. Tallian | |
Date | Peter J. Tallian Senior Vice President, Chief Financial Officer and Treasurer (Chief Financial Officer and Chief Accounting Officer) |
45